UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended: ~~March~~June 3130, 2025

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Transition Period from ___________ to____________

Commission File Number: 333-257458

CYTTA CORP.

(Exact name of registrant as specified in its charter)

Nevada

98-0505761

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

5450 W Sahara Ave Suite 300A

Las Vegas NV 89146

(Address of principal executive offices) (zip code)

(702) 900-7022

(Registrant’s telephone number, including area code)

Not applicable.

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		N/A		N/A

Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.001 par value

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes ☒ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated Filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

As of ~~September~~October 3029, 2025, there were ~~470~~480,237,826 shares outstanding of the registrant’s common stock, $0.001 par value per share.

CYTTA CORP.

INDEX

PART I. FINANCIAL INFORMATION
ITEM 1	Financial Statements (Unaudited)
	Balance Sheets as of March 31, 2025 (unaudited), and September 30, 2024	3
	Consolidated Balance Sheets as of June 30, 2025 (unaudited), and September 30, 2024	3
	Statements of Operations for the three and six months ended March 31, 2025, and 2024 (Unaudited)	4
	Consolidated Statements of Operations for the three and nine months ended June 30, 2025, and 2024 (Unaudited)	4
	Statements of Changes in Stockholders’ Equity (Deficit) for the three and six months ended March 31, 2025, and 2024 (Unaudited)	5
	Consolidated Statements of Changes in Stockholders’ Equity (Deficit) for the three and nine months ended June 30, 2025, and 2024 (Unaudited)	5
	Statements of Cash Flows for the six months ended March 31, 2025, and 2024 (Unaudited)	7
	Consolidated Statements of Cash Flows for the nine months ended June 30, 2025, and 2024 (Unaudited)	7
	Notes to Interim Unaudited Financial Statements	8
	Notes to Interim Unaudited Consolidated Financial Statements	8
ITEM 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	25
ITEM 3.	Quantitative and Qualitative Disclosures About Market Risk	2829
ITEM 4.	Controls and Procedures	2829
PART II. OTHER INFORMATION
ITEM 1.	Legal Proceedings	30
ITEM 1A.	Risk Factors	30
ITEM 2.	Unregistered Sales of Equity Securities and Use of Proceeds	30
ITEM 3.	Defaults Upon Senior Securities	30
ITEM 4.	Mine Safety Disclosures	30
ITEM 5.	Other Information	30
ITEM 6.	Exhibits	31

Table of Contents

CYTTA CORP ~~BALANCE SHEETS~~

	March 31,			September 30,
	2025			2024
ASSETS	(unaudited)
Current Assets
Cash	$	629,061		$	1,439,835
Prepaid expenses- related party		351,091			421,334
Prepaid expenses- other		16,135			122,712
Marketable securities at fair value		6,489,441			-
Security deposits		6,500			-
Total Current Assets		7,492,228			1,983,881
Prepaid expenses, non-current		-			140,443
Property and equipment, net		34,412			50,867
TOTAL ASSETS	$	7,526,640		$	2,175,191
LIABILITIES AND STOCKHOLDERS' DEFICIT
Liabilities
Current Liabilities
Accounts payable and accrued expenses	$	609,720		$	524,251
Related party liabilities		403,175			413,093
Dividend payable		33,427			33,427
Deferred revenue		416			2,914
Convertible notes payable		305,950			1,438,950
Total Current Liabilities and Total Liabilites		1,352,688			2,412,635
COMMITMENTS AND CONTINGENCIES		-			-
Stockholders' Equity (Deficit)
Preferred stock par value $0.001; (100,000,000 shares authorized)
Series C Preferred Stock par value $0.001; (12,000,000 shares authorized and 600,000 shares issued and outstanding)		600			600
Series D Preferred Stock par value $0.001; (10,000,000 shares authorized and 50,000 shares issued and outstanding)		50			50
Series E Preferred Stock par value $0.001; (13,650,000 shares authorized and -0- issued and outstanding)		-			-
Series F Preferred Stock par value $0.001; (59,270,000 shares authorized and -0- issued and outstanding)		-			-
Common stock par value $0.001; (600,000,000 shares authorized and 470,237,826 (2025) and 469,877,826 (2024) shares issued and outstanding)		470,239			469,879
Additional paid in capital		37,073,274			36,159,919
Accumulated deficit		(31,370,211	)		(36,867,892	)
Total Stockholders' Equity (Deficit)		6,173,952			(237,444	)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$	7,526,640		$	2,175,191

CONSOLIDATED BALANCE SHEETS

	June 30,			September 30,
	2025			2024
ASSETS	(unaudited)
Current Assets
Cash	$	416,892		$	1,439,835
Prepaid expenses- related party		245,763			421,334
Prepaid expenses- other		12,616			122,712
Marketable securities at fair value		4,747,302			-
Security deposits		6,500			-
Total Current Assets		5,429,073			1,983,881

Prepaid expenses, non-current		-			140,443
Property and equipment, net		24,505			50,867
TOTAL ASSETS	$	5,453,578		$	2,175,191

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Liabilities
Current Liabilities
Accounts payable and accrued expenses	$	637,138		$	524,251
Related party liabilities		432,371			413,093
Dividend payable		33,427			33,427
Deferred revenue		-			2,914
Convertible notes payable		305,950			1,438,950
Total Current Liabilities and Total Liabilities		1,408,886			2,412,635

COMMITMENTS AND CONTINGENCIES		-			-

Stockholders' Equity (Deficit)
Preferred stock par value $0.001; (100,000,000 shares authorized) Series A Preferred Stock par value $0.001; (10,000,000 shares authorized and -0- shares issued and outstanding)		-			-
Series C Preferred Stock par value $0.001; (12,000,000 shares authorized and 600,000 shares issued and outstanding)		600			600
Series D Preferred Stock par value $0.001; (10,000,000 shares authorized and 50,000 shares issued and outstanding)		50			50
Series E Preferred Stock par value $0.001; (13,650,000 shares authorized and -0- issued and outstanding)		-			-
Series F Preferred Stock par value $0.001; (59,270,000 shares authorized and -0- issued and outstanding)		-			-
Common stock par value $0.001; (600,000,000 shares authorized and 470,237,826 (2025) and 469,877,826 (2024) shares issued and outstanding)		470,239			469,879
Additional paid in capital		37,073,274			36,159,919
Accumulated deficit		(33,499,471	)		(36,867,892	)
Total Stockholders' Equity (Deficit)		4,044,692			(237,444	)

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$	5,453,578		$	2,175,191

The accompanying notes are an integral part of these unaudited financial statements

Table of Contents

CYTTA CORP ~~STATEMENTS OF OPERATIONS (Unaudited)~~

	For the Three Months Ended March 31,						For the Six Months Ended March 31,
	2025			2024			2025			2024
Revenues	$	1,249		$	-		$	2,498		$	2,411
Cost of revenues		18,632			-			37,091			-
Gross Profit (loss)		(17,383	)		-			(34,593	)		2,411
Operating Expenses:
General and administrative - related party		221,340			216,834			443,078			430,042
General and administrative - other		340,694			688,876			761,163			1,466,120
Total operating expenses		562,034			905,710			1,204,241			1,896,162
Loss from Operations		(579,417	)		(905,710	)		(1,238,834	)		(1,893,751	)
Other expenses (income)
Interest expense		73,044			82,954			137,746			154,241
Loss on settlement of debt		787,637			-			787,637			-
Interest income		-			(123	)		-			(323	)
Gain on fair value change of marketable securities		(7,661,898	)		-			(7,661,898	)		-
Total Other Expenses (Income)		(6,801,217	)		82,831			(6,736,515	)		153,918
Income (loss) before income taxes		6,221,800			(988,541	)		5,497,681			(2,047,669	)
Provision for income taxes		-			-			-			-
Net income (loss)	$	6,221,800		$	(988,541	)	$	5,497,681		$	(2,047,669	)
Income (Loss) per share, basic	$	0.01		$	(0.00	)	$	0.01		$	(0.00	)
Income (Loss) per share, diluted	$	0.01		$	(0.00	)	$	0.01		$	(0.00	)
Weighted average shares outstanding, basic		470,137,826			440,663,814			470,006,397			434,586,858
Weighted average shares outstanding, diluted		543,726,146			440,663,814			543,594,717			434,586,858
The accompanying notes are an integral part of these unaudited financial statements

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	For the Three Months Ended June 30,						For the Nine Months Ended June 30,
	2025			2024			2025			2024

Revenues	$	416		$	832		$	2,914		$	3,243
Cost of revenues		13,194			-			50,285			-
Gross Profit (Loss)		(12,778	)		832			(47,371	)		3,243

Operating Expenses:
General and administrative - related party		216,860			222,433			659,938			652,475
General and administrative - other		143,330			1,073,314			904,493			2,539,434
Total operating expenses		360,190			1,295,747			1,564,431			3,191,909

Loss from Operations		(372,968	)		(1,294,915	)		(1,611,802	)		(3,188,666	)

Other expenses (income)
Interest expense		14,154			159,041			151,900			313,282
Loss on settlement of debt		-			-			787,637			-
Interest income		-			(179	)		-			(502	)
Loss (gain) on fair value change of marketable securities		1,742,138			-			(5,919,760	)		-
Total Other Expenses (Income)		1,756,292			158,862			(4,980,223	)		312,780

Income (loss) before income taxes		(2,129,260	)		(1,453,777	)		3,368,421			(3,501,446	)
Provision for income taxes		-			-			-			-
Net income (loss)	$	(2,129,260	)	$	(1,453,777	)	$	3,368,421		$	(3,501,446	)

Income (Loss) per share, basic	$	(0.00	)	$	(0.00	)	$	0.01		$	(0.01	)
Income (Loss) per share, diluted	$	(0.00	)	$	(0.00	)	$	0.01		$	(0.01	)

Weighted average shares outstanding, basic		470,237,826			458,786,278			470,083,540			442,623,891
Weighted average shares outstanding, diluted		470,237,826			458,786,278			544,222,618			442,623,891

The accompanying notes are an integral part of these unaudited financial statements

Table of Contents

~~Cytta~~CYTTA ~~Corp. STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) The Six Months Ended March 31, 2025 (Unaudited)~~CORP

	Series C Preferred Stock				Series D Preferred Stock				Series E Preferred Stock				Series F Preferred Stock				Common Stock				Paid-in		Accumulated			Stockholders'Equity
	Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			(Deficit)
Balance September 30, 2024		600,000	$	600		50,000	$	50		-	$	-		-	$	-		469,877,826	$	469,879	$	36,159,919	$	(36,867,892	)		(237,444	)
Net loss for the three months ended December 31, 2024		-		-		-		-		-		-		-		-		-		-		-		(724,119	)		(724,119	)
Balance December 31, 2024		600,000		600		50,000		50		-		-		-		-		469,877,826		469,879		36,159,919		(37,592,011	)		(961,563	)
Issuance of Reticulate Micro common stock for convertible notesand accrued interest conversion		-		-		-		-		-		-		-		-		-		-		905,579		-			905,579
Common stock issued for accounts payable and accrued liabilities		-		-		-		-		-		-		-		-		360,000		360		7,776		-			8,136
Net income for the three months ended March 31, 2025		-		-		-		-		-		-		-		-		-		-		-		6,221,800			6,221,800
Balance March 31, 2025		600,000	$	600		50,000	$	50		-	$	-		-	$	-		470,237,826	$	470,239	$	37,073,274	$	(31,370,211	)	$	6,173,952

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

The Nine Months Ended June 30, 2025

(Unaudited)

	Series C				Series D								Additional					Total
	Preferred Stock				Preferred Stock				Common Stock				Paid-in		Accumulated			Stockholders'
	Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			Equity (Deficit)
Balance September 30, 2024		600,000	$	600		50,000	$	50		469,877,826	$	469,879	$	36,159,919	$	(36,867,892	)		(237,444	)


Net loss for the three months ended December 31, 2024		-		-		-		-		-		-		-		(724,119	)		(724,119	)
Balance December 31, 2024		600,000		600		50,000		50		469,877,826		469,879		36,159,919		(37,592,011	)		(961,563	)

Issuance of Reticulate Micro common stock for convertible notes
and accrued interest conversion		-		-		-		-		-		-		905,579		-			905,579

Common stock issued for accounts payable and accrued liabilities		-		-		-		-		360,000		360		7,776		-			8,136

Net income for the three months ended March 31, 2025		-		-		-		-		-		-		-		6,221,800			6,221,800
Balance March 31, 2025		600,000		600		50,000		50		470,237,826		470,239		37,073,274		(31,370,211	)		6,173,952

Net loss for the three months ended June 30, 2025		-		-		-		-		-		-		-		(2,129,260	)		(2,129,260	)
Balance June 30, 2025		600,000	$	600		50,000	$	50		470,237,826	$	470,239	$	37,073,274	$	(33,499,471	)	$	4,044,692

Table of Contents

~~Cytta~~CYTTA ~~Corp. STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) The Six Months Ended March 31, 2024 (Unaudited)~~CORP

	Series C Preferred Stock				Series D Preferred Stock				Series E Preferred Stock				Series F Preferred Stock				Common Stock				Paid-in		Accumulated			Total
	Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit
Balances September 30, 2023		600,000	$	600		50,000	$	50		-	$	-		-	$	-		426,831,170	$	426,832	$	31,915,639	$	(32,603,480	)	$	(260,359	)
Common stock and warrants issued for services		-		-		-		-		-		-		-		-		6,000,000		6,000		163,200		-			169,200
Common stock issued for accounts payable and accrued liabilities		-		-		-		-		-		-		-		-		1,887,750		1,888		48,893		-			50,781
Net loss for the three months ended December 31, 2023		-		-		-		-		-		-		-		-		-		-		-		(1,059,128	)		(1,059,128	)
Balance Deember 31, 2023		600,000		600		50,000		50		-		-		-		-		434,718,920		434,720		32,127,732		(33,662,608	)		(1,099,505	)
Common stock issued for services		-		-		-		-		-		-		-		-		5,000,000		5,000		99,000		-			104,000
Common stock issued for accounts payable and accrued liabilities		-		-		-		-		-		-		-		-		2,227,661		2,228		44,108		-			46,336
Warrants vested to purchase common stock		-		-		-		-		-		-		-		-		-		-		272,299		-			272,299
Net loss for the three months ended March 31, 2024		-		-		-		-		-		-		-		-		-		-		-		(988,541	)		(988,541	)
Balance March 31, 2024		600,000	$	600		50,000	$	50		-	$	-		-	$	-		441,946,581	$	441,948	$	32,543,139	$	(34,651,149	)	$	(1,665,411	)

CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)

The Nine Months Ended June 30, 2024

(Unaudited)

	Series C				Series D								Additional					Total
	Preferred Stock				Preferred Stock				Common Stock				Paid-in		Accumulated			Stockholders'
	Shares		Amount		Shares		Amount		Shares		Amount		Capital		Deficit			Equity (Deficit)
Balances September 30, 2023		600,000	$	600		50,000	$	50		426,831,170	$	426,832	$	31,915,639	$	(32,603,480	)	$	(260,359	)

Common stock and warrants issued for services		-		-		-		-		6,000,000		6,000		163,200		-			169,200

Common stock issued for accounts payable and accrued liabilities		-		-		-		-		1,887,750		1,888		48,893		-			50,781

Net loss for the three months ended December 31, 2023		-		-		-		-		-		-		-		(1,059,128	)		(1,059,128	)
Balance December 31, 2023		600,000		600		50,000		50		434,718,920		434,720		32,127,732		(33,662,608	)		(1,099,506	)

Common stock issued for services		-		-		-		-		5,000,000		5,000		99,000		-			104,000

Common stock issued for accounts payable and accrued liabilities		-		-		-		-		2,227,661		2,228		44,108		-			46,336

Warrants vested to purchase common stock		-		-		-		-		-		-		272,299		-			272,299

Net loss for the three months ended March 31, 2024		-		-		-		-		-		-		-		(988,541	)		(988,541	)
Balance March 31, 2024		600,000		600		50,000		50		441,946,581		441,948		32,543,139		(34,651,149	)		(1,665,412	)

Common stock issued for services		-		-		-		-		20,000,000		20,000		501,150		-			521,150

Common stock issued for accounts payable and accrued liabilities		-		-		-		-		2,371,687		2,372		66,440		-			68,812

Common stock issued for accounts payable and accrued liabilities, related party		-		-		-		-		3,000,000		3,000		87,000		-			90,000

Warrants issued and vested to purchase Reticulate Micro common stock		-		-		-		-		-		-		119,348		-			119,348

Issuance of Reticulate Micro common stock for convertible note and
accrued interest conversion		-		-		-		-		-		-		2,425,106		-			2,425,106

Net loss for the three months ended June 30, 2024		-		-		-		-		-		-		-		(1,453,777	)		(1,453,777	)
Balance June 30, 2024		600,000	$	600		50,000	$	50		467,318,268	$	467,320	$	35,742,183	$	(36,104,926	)	$	105,226

The accompanying notes are an integral part of these unaudited financial statements

Table of Contents

Cytta Corp.
STATEMENTS OF CASH FLOWS
(Unaudited)
	For the Six Months Ended March 31,
	2025			2024
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	5,497,681		$	(2,047,669	)
Adjustments to reconcile net income (loss) to net
cash used in operating activities:
Stock-based compensation expenses for services - related party		247,167			250,042
Stock-based compensation expenses for services - other		228,856			742,000
Gain on change in fair value of marketable securities		(7,661,898	)		-
Loss on issunace of RM stock for debt extinguishment		787,637			-
Amortization of note discounts		-			30,706
Gain on debt extinguishment		(864	)		(4,834	)
Depreciation expense		19,455			21,084
Changes in Operating Assets and Liabilities:
Prepaid expenses - other		(14,378	)		65,436
Accounts payable and accrued liabilities		143,986			126,946
Accounts payable-related party		(46,418	)		28,040
Deferred revenue		(2,498	)		(2,411	)
Security deposits		(6,500	)		-
Net cash used in operating activities		(807,774	)		(790,660	)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment		(3,000	)		-
Net cash used in investing activities		(3,000	)		-
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of short-term convertible note payable		-			557,500
Net cash provided by financing activities		-			557,500
NET CHANGE IN CASH		(810,774	)		(233,160	)
CASH AT BEGINNING OF PERIOD		1,439,835			674,824
CASH AT END OF PERIOD	$	629,061		$	441,664
SUPPLEMENTAL CASH FLOW DISCLOSURES
Cash paid for interest	$	-		$	-
Cash paid for income taxes	$	-		$	-
NON-CASH INVESTING AND FINANCING ACTIVITIES
Common stock issued for services	$	-		$	273,200
Common stock issued for accounts payable and accrued liabilities	$	8,136		$	101,949
Settlement of convertible notes and accrued interest by transfer of Reticulate Micro common stock	$	1,290,400		$	-
The accompanying notes are an integral part of these unaudited financial statements

CYTTA CORP

STATEMENTS OF CASH FLOWS

(Unaudited)

	For the Nine Months Ended June 30,
	2025			2024

CASH FLOWS FROM OPERATING ACTIVITIES

Net income (loss)	$	3,368,421		$	(3,501,446	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Stock-based compensation expenses for services - related party		365,325			374,751
Stock-based compensation expenses for services - other		233,606			1,317,126
Gain on change in fair value of marketable securities		(5,919,760	)		-
Loss on issuance of RM stock for debt extinguishment		787,637			-
Amortization of note discounts		-			46,060
Gain on debt extinguishment		(864	)		(14,291	)
Depreciation expense		29,362			31,103
Changes in Operating Assets and Liabilities:
Prepaid expenses - other		(10,865	)		76,687
Accounts payable and accrued liabilities		166,656			243,854
Accounts payable-related party		(30,047	)		13,040
Deferred revenue		(2,914	)		1,752
Security deposits		(6,500	)		-
Net cash used in operating activities		(1,019,943	)		(1,411,364	)

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment		(3,000	)		(14,707	)
Net cash used in investing activities		(3,000	)		(14,707	)

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from issuance of short-term convertible note payable		-			2,468,450
Net cash provided by financing activities		-			2,468,450

NET CHANGE IN CASH		(1,022,943	)		1,042,379
CASH AT BEGINNING OF PERIOD		1,439,835			674,824
CASH AT END OF PERIOD	$	416,892		$	1,717,203

SUPPLEMENTAL CASH FLOW DISCLOSURES

Cash paid for interest	$	-		$	-
Cash paid for income taxes	$	-		$	-

NON-CASH INVESTING AND FINANCING ACTIVITIES

Common stock issued for services	$	-		$	794,350
Common stock issued for accounts payable and accrued liabilities	$	8,136		$	160,251
Common stock issued for accrued expenses, related party	$	-		$	108,250
Reticulate Micro common stock issued for convertible notes and accrued interest	$	1,290,400		$	2,425,106

The accompanying notes are an integral part of these unaudited financial statements

Table of Contents

~~Cytta~~CYTTA ~~Corp.~~CORP

Notes to Financial Statements

~~March~~June 3130, 2025

(Unaudited)

NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS

Cytta Corp., (“Cytta” or the “Company”) was incorporated on May 30, 2006, under the laws of the State of Nevada. It is located in Las Vegas, Nevada. Cytta is in the business of imagineering, developing and securing disruptive technologies.

The Company's proprietary CyttaCOMMS incident management software system offers real-time integration of video and audio streams, enabling improved collaboration and providing ongoing, relevant, actionable intelligence. Their innovative new product, CyttaCARES, is a game-changer in ensuring the safety and well-being of individuals in educational institutions and beyond. Cytta's CyttaCOMP ISTAR (Intelligence, Surveillance, Target Acquisition and Reconnaissance) technology delivers real-time compression of video streams with ultra-low latency, even in low bandwidth environments in conjunction with their compression Licensee Reticulate Micro, Inc.

Cytta’s proprietary SUPR Intelligence, Surveillance and Reconnaissance (ISR) technology designated CyttaCOMP, is now licensed to Reticulate Micro, Inc. CyttaCOMP, is at the core of our products and is the most potent software compression codec commercially available. CyttaCOMP is explicitly designed for realtime streaming of HD, 4K, and higher resolution video while requiring only limited bandwidth and minimal computational resources.

Cytta’s CyttaCOMMS (formerly IGAN^TMIncident Command System (ICS) system) seamlessly streams and integrates all available video and audio sources during emergencies, enabling sharing of multiple video and audio inputs. The trial (MVP- Minimum Viable Product) version of the CyttaCOMMS product was introduced into the market in the last quarter of 2024. Based upon the information gathered the all of the MVP versions utilizations of the CyttaCOMMS were terminated and the server-side architecture redesigned for an enterprise level sales program when the product is upgraded to incorporate the missing functionality requested. The Company is currently working to finalize the MMP (Minimum Marketable Product) version of the CyttaCOMMS software designated CyttaCOMMS 2.0 for the marketplace.

The CyttaCOMMS online software platform is fully SaaS based with no hardware components. CyttaCOMMS introduces immediate real-time video and audio situational awareness, which is valuable for police, firefighters, first responders, emergency medical workers, industry, environmental and emergencies, security, military, and all their command centers in any emergency. The proprietary IGAN^TM software technology powers Cytta’s SaaS based COMMS system and creates an integrated communications platform which seamlessly streams all available video and audio sources in all critical situations, for first responders enabling real time event and interactive mapping information.

Also based upon the IGAN^TM technology, Cytta’s CyttaCARES (Crisis Alert and Response Emergency System) system is an innovative SAAS solution designed to enhance safety and security in educational institutions, especially during emergency situations. This comprehensive system provides real-time alerts, rapid two-way secure video communication, and efficient response coordination with live location tracking to emergency response teams. The CyttaCARES system has reached the trial or MVP stage, however because of the sensitive nature of the technology the product will require additional work to bring it to the MMP stage, before we begin live school demonstrations.

We have created advanced video compression (SUPR), video/audio streaming and collaboration software (CyttaCOMMS), and school and institution safety and security software systems (CyttaCARES) that solve real world streaming, safety and security problems for multiple institutions and organizations. We believe our products will enable and empower the world to consume higher quality video anywhere, anytime while providing unparallelled safety and security.

On May 13, 2025, the Company formed Cytta Labs Inc (Cytta Labs) as a Wyoming Corporation. Cytta Labs was formed to be a next generation venture studio, and the strategic evolution of Cytta Corp into an innovation holding company focused on IP, equity ownership, and long-term value creation.

Table of Contents

NOTE 2 - GOING CONCERN

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of ~~March~~June 3130, 2025, the Company had an accumulated deficit of $3133,~~370~~499,~~211~~471, and limited revenues. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these uncertainties.

The Company intends to fund operations through equity and/or debt financing arrangements, which may not be sufficient to fund its capital expenditures, working capital and other cash requirements for the foreseeable future.

NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and consolidation

The accompanying unaudited consolidated financial statements include the accounts of the Company and Cytta Labs, the Company’s wholly owned subsidiary, and have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June ~~March 31~~30, 2025, and the results of operations and cash flows for the periods presented. The results of operations for the three and ~~six~~nine months ended ~~March~~June 3130, 2025, are not necessarily indicative of the operating results for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the audited financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K filed on January 14, 2025, for the year ended September 30, 2024. As of June 30, 2025, there has been no activity in Cytta Labs.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.

Reclassifications

Certain prior period amounts have been reclassified to conform with the current period presentation.

Cash and Cash Equivalents

The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits of $250,000 per financial institution. The amount in excess of the FDIC insurance as of ~~March~~June 3130, 2025, was approximately $~~379~~167,000. The Company has no cash equivalents at ~~December~~June 3130, ~~2024~~2025, and September 30, 2024.

Table of Contents

Prepaid expenses

The Company considers expenses or services paid for prior to the period the expense is incurred to be recorded as a prepaid expense. Included in this account is the value of common stock, options and warrants issued to consultants. Such issuances are pursuant to consulting agreements that can have a one-to-three-year term. The Company amortized the value of the stock issued over the term of the agreement. The activity for the ~~six~~nine months ended ~~March~~June 3130, 2025, and the year ended September 30, 2024, is summarized as:

	March 31, 2025			September 30, 2024
	June 30, 2025			September 30, 2024
Balance beginning of period	$	684,489		$	1,548,752
Stock-based compensation					309,550
Amortization of stock-based compensation		(~~331~~436,~~641~~975	)		(1,093,370	)
Other prepaid expense activity		1410,~~378~~865			(80,443	)
Sub-total		~~367~~258,~~226~~379			684,489
Less non-current portion (all related party)		-			140,443
Prepaid expenses, current portion		~~367~~258,~~226~~379			544,046
Less prepaid expenses – related party, current portion		~~351~~245,~~091~~763			421,334
Prepaid expenses – other, current portion	$	1612,~~135~~616		$	122,712

Marketable Securities at fair value

Marketable Securities consists of Class A Common Shares of RMX Industries, Inc.(formerly Reticulate Micro, Inc. (RM)) that the Company carries at fair value and are expected to be liquidated within one year from the balance sheet date, are classified as Current Assets.

The Company accounts for marketable and available-for-sale securities under ASU 2016-01, “Financial Instruments – Overall: Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income.

At ~~March~~June 3130, 2025, the Company owned 2,434,513 shares and the fair value was reported on the balance sheet as Marketable securities at fair value of $64,~~489~~747,~~441~~302 ($21.~~6656~~95/share). The Company recorded ~~an adjustment of~~ $71,~~661~~742,~~898~~ 138 as unrealized loss for the three ~~and six~~ months ending ~~March~~June 3130, 2025, and $5,919,760, as unrealized gain for the nine months ending June 30, 2025, on fair value ~~change~~changes of marketable securities and is ~~reported~~included asin Other Expenses (Income).

Property and equipment

Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets.

The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows:

Vehicles and equipment	5 years
Software	3 years

Convertible Instruments

The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities.

GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.

Table of Contents

In August 2020, the FASB issued Accounting Standards Update 2020-06 (ASU 2020-06). ASU 2020-06 eliminates the beneficial conversion feature and cash conversion models in Accounting Standards Codification 470-20 that require separate accounting for embedded conversion features in convertible instruments. The new guidance also eliminates some of the conditions that must be met for equity classification under ASC 815-40-25. The standard is effective for smaller reporting companies for annual periods beginning after December 15, 2023. Early adoption is permitted. The Company chose to early adopt this standard. As a result, financial results contained herein are reported in accordance with this standard as applicable.

The convertible debt issued by the Company referred to in Note 7, did not require separate accounting for the conversion feature as it was not considered to be a derivative. The Company issued warrants in connection with the debt financing and in accordance with ASC 470-20-25-2 the proceeds from the sale of the debt instruments have been allocated to the debt and warrants based on the relative fair value of the two components. The amount allocated to the warrants has been recorded as a debt discount to be amortized of the life of the note.

Fair value of financial instruments

The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level.

The following are the hierarchical levels of inputs to measure fair value:

	·	Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities.
	·	Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
	·	Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available.

The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, accounts payable and accrued expenses, related party liabilities, and deferred revenue, approximate their fair values because of the short maturity of these instruments.

The Company measures the Reticulate Micro common stock it holds at fair value on a recurring basis. The activity for the ~~six~~nine months ended ~~March~~June 3130, 2025, is as follows:

	March 31, 2025
	June 30, 2025
Beginning balance	$	-
Initial value of 2,664,609 RM shares at $3.75 per share		9,992,284
Settlement of convertible notes and accrued interest via transfer of 230,095 RM shares		(1,172,453	)
Changes in fair value		(24,~~330~~072,~~390~~529	)
Ending balance March 31, 2025	$	6,489,441
Ending balance June 30, 2025	$	4,747,302

Table of Contents

Revenue recognition

Our revenues are primarily generated from fees charged in connection with the implementation of our software platform (including the sale of SaaS products and services, maintenance associated with the sale of on premise software licenses).

Our revenue recognition policy follows the guidance from Accounting Standards Codification (“ASC”) 606, “Revenue Recognition,” and Accounting Standards Update No. 2014-09 – Revenue from Contracts with Customers (Topic 606) which provide guidance on the recognition, presentation, and disclosure of revenue in financial statements. We determine revenue recognition through the following steps: (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract and (v) recognition of revenue when a performance obligation is satisfied.

11 Table of Contents

Revenue from fees charged in connection with the implementation of our software platform is recognized ratably over the term specified with the customers, which is primarily one year. The transaction price is the amount of consideration to which the Company expects to be entitled to receive in exchange for providing access to its platform. Maintenance and support services generally call for the Company to provide software updates and technical support to customers and is recognized ratably over the term of the contract as this is the period the services are delivered. The Company does not view the provision of initial setup services as a discrete earnings event that is distinct. Our standard payment terms are generally no more than 60 days. SaaS and maintenance services are typically invoiced annually in advance. Amounts billed or collected in excess of revenue recognized are included as deferred revenue.

Accounts receivable

The Company records accounts receivable at the time services are invoiced when the access to our platform is delivered or provided to the customers. An allowance for losses is established through a provision for losses charged to expenses. Receivables are charged against the allowance for losses when management believes collectability is unlikely. The allowance (if any) is an amount that management believes will be adequate to absorb estimated losses on existing receivables, based on evaluation of the collectability of the accounts and prior loss experience.

Stock-based compensation

The Company accounts for its stock based compensation under the recognition and measurement principles of the fair value recognition provisions of Statement of Financial Accounting Standards No. 123 (revised 2004) “Share-Based Payment” (ASC 718) using the modified prospective method for transactions in which the Company obtains employee services in share-based payment transactions and the Financial Accounting Standards Board Emerging Issues Task Force Issue No. 96-18 “Accounting For Equity Instruments That Are Issued To Other Than Employees For Acquiring, Or In Conjunction With Selling Goods Or Services” (“EITF No. 96-18”) for share-based payment transactions with parties other than employees provided in (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the grant date.

Income taxes

The Company accounts for income taxes under Statement of Financial Accounting Standards No. 109 “Accounting for Income Taxes” (“SFAS No. 109”) (ASC 740). Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date.

Table of Contents

Cash flows reporting

The Company follows the provisions of ASC 230 for cash flows reporting and accordingly classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by ASC 230 to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.

12 Table of Contents

Reporting segments

ASC 280 establishes standards for the way that public enterprises report information about operating segments in annual financial statements and requires reporting of selected information about operating segments in interim financial statements regarding products and services, geographic areas and major customers. ASC 280 defines operating segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performances. Currently, ASC 280 has no effect on the Company’s financial statements as substantially all of the Company’s operations are conducted in one industry segment.

Concentrations of Credit Risk

The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.

Earnings (Loss) Per Share of Common Stock

The Company has adopted ASC 260-10-20, “Earnings per Share,” (“EPS”) which requires presentation of basic and diluted EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation.

In the accompanying financial statements, basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.

To calculate fully diluted earnings per share, the Company uses the Treasury Stock Method. This methodology adds to the Weighted Average Shares Outstanding the number of additional shares that could potentially be issued pursuant to the conversion of all of the Company’s in-the-money outstanding convertible securities (including options, warrants and debt), with the further assumptions that all funds (if any) received pursuant to the conversions would be used to purchase the maximum number of shares at the average price per share for the period in order to offset and minimize the dilution effects. Fully Diluted Earnings Per Share is calculated by dividing Net Income by the adjusted Average Weighted Average Shares Outstanding.

The following table represents the classes of dilutive securities as of ~~March~~June 3130, 2025, and 2024:

	March 31,2025		March 31,2024
	June 30,2025		June 30,2024
Series C Preferred Stock		60,000,000		60,000,000
Series D Preferred Stock		50,000		50,000
Convertible notes payable		1314,~~538~~089,~~320~~078		7356,~~525~~288,~~720~~838
Unexercised options and warrants		24,000,000		28,000,000
Total		9798,~~588~~139,~~320~~078		~~161~~144,~~575~~388,~~720~~838

The following table represents the basic and diluted weighted average shares outstanding for the three and six months ended March 31, 2025, and 2024:

	Three months ended March 31,				Six months ended March 31,
Description	2025		2024		2025		2024
Basic weighted average shares outstanding		470,137,826		440,663,814		470,006,397		434,586,858
Convertible notes payable		13,538,320		-		13,538,320		-
Series C Preferred Stock		60,000,000		-		60,000,000		-
Series D Preferred Stock		50,000		-		50,000		-
Total		543,726,146		440,663,814		543,594,717		434,586,858

Table of Contents

	Three months ended March 31,					Six months ended March 31,
Fully Diluted Earnings (loss) per share	2025		2024			2025		2024
Net income (loss)	$	6,221,800	$	(988,541	)	$	5,497,681	$	(2,047,669	)
Adjustments		13,768		-			27,536		-
Adjusted net income (loss)		6,235,568		(988,541	)		5,525,217		(2,047,669	)
Weighted average number of common shares outstanding		470,137,826		440,663,814			470,006,397		434,586,858
Shares computed on if converted basis		73,588,320		-			73,588,320		-
Total number of shares on fully diluted basis		543,726,146		440,663,814			543,594,717		434,586,858
Fully diluted earnings (loss) per share	$	0.01	$	(0.00	)	$	0.01	$	(0.01	)

The following table represents the basic and diluted weighted average shares outstanding for the three and nine months ended June 30, 2025, and 2024:

	Three months ended June 30,				Nine months ended June 30,
Description	2025		2024		2025		2024
Basic weighted average shares outstanding		470,237,826		458,786,278		470,083,540		442,623,891
Convertible notes payable		-		-		14,089,078		-
Series C Preferred Stock		-		-		60,000,000		-
Series D Preferred Stock		-		-		50,000		-
Total		470,237,826		458,786,278		544,222,618		442,623,891

	Three months ended June 30,						Nine months ended June 30,
Fully Diluted Earnings (loss) per share	2025			2024			2025		2024
Net income (loss)	$	(2,129,260	)	$	(1,453,777	)	$	3,368,421	$	(3,501,446	)
Adjustments		-			-			41,303		-
Adjusted net income (loss)		(2,129,260	)		(1,453,777	)		3,404,724		(3,501,446	)
Weighted average number of common shares outstanding		470,237,826			458,786,278			470,083,540		442,623,891
Shares computed on if converted basis		-			-			74,139,078		-
Total number of shares on fully diluted basis		470,237,826			458,786,278			544,222,618		442,623,891
Fully diluted earnings (loss) per share	$	(0.00	)	$	(0.00	)	$	0.01	$	(0.01	)

Recent Accounting Pronouncements

There have been no recent accounting pronouncements or changes in accounting pronouncements during the ~~six~~nine months ended ~~March~~June 3130, 2025, that are of significance or potential significance to the Company.

NOTE 4 - PROPERTY AND EQUIPMENT

The following table represents the Company’s property and equipment as of ~~March~~June 3130, 2025, and September 30, 2024:

	March 31,2025			September 30,2024
	June 30,2025			September 30,2024
Property and equipment	$	248,606		$	245,606
Accumulated depreciation		(~~214~~224,~~194~~101	)		(194,739	)
Property and equipment, net	$	3424,~~412~~505		$	50,867

Depreciation expense was $9,~~191~~907 and $1929,~~455~~362 for the three and ~~six~~nine months ended ~~March~~June 3130, 2025, respectively, and $10,~~508~~019 and $2131,~~084~~103 for the three and ~~six~~nine months ended ~~March~~June 3130, 2024, respectively.

Table of Contents

NOTE 5 - RELATED PARTY TRANSACTIONS

Related Party agreements and fees

For the three and ~~six~~nine months ended ~~March~~June 3130, 2025, and 2024, the Company recorded expenses to related parties in the following amounts:

	Three months ended March 31,				Six months ended March 31,
	Three months ended June 30,				Nine months ended June 30,
Description	2025		2024		2025		2024
CEO-Management fees	$	45,000	$	45,000	$	90135,000	$	90135,000
President and Chief Operating Officer		45,000		45,000		90135,000		90135,000
Stock-based compensation expense, officers		~~123~~118,~~384~~158		~~126~~124,~~834~~708		~~247~~365,~~167~~325		~~250~~374,~~042~~750
Office rent and expenses		78,~~956~~702		-7,725		1524,~~911~~613		-7,725
Total	$	~~221~~216,~~340~~860	$	~~216~~222,~~834~~433	$	~~443~~659,~~078~~938	$	~~430~~652,~~042~~475

Effective January 1, 2023, the monthly fee for the CEO was $15,000.

Effective February 1, 2023, the Company entered a Consulting Executive Officer Agreement with a three- year term to an entity (SGG World LLC or "SGG") to provide the services of a Chief Operating Officer (the “COO”) of the Company. On October 1, 2023, the BOD also appointed the COO as the President. Pursuant to the agreement, the Company agreed to a monthly fee of $10,000, and the issuance of 250,000 common shares per month, to be issued semi-annually. The monthly fee was increased to $15,000 per month effective September 1, 2023. For the three months and ~~six~~nine months ended ~~March~~June 3130, 2025, the Company recorded expenses of $1812,~~050~~825 and $3649,~~500~~326, respectively, and $2119,~~500~~375 and $3958,~~375~~750, respectively, for the three and ~~six~~nine months ended ~~March~~June 3130, 2024, related to the 250,000 common shares per month, calculated based on the closing market price of the common stock on the last day of each month.

14The ~~Table~~Company granted an option to SGG purchase 10,000,000 shares of ~~Contents~~the Company’s common stock at $0.02 per share with an expiry date of July 1, 2025 (the "CYCA Option”). The CYCA option vests at the rate of 25% beginning on the first six-month anniversary of the agreement, as well as a warrant to purchase 250,000 shares of the Reticulate Micro common stock the Company owns (the “RM Warrant”). The RM Warrant has an exercise price of $1.00 per share and an expiry date of July 1, 2025. The Company valued the CYCA Option at $639,543 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $53,295 and $159,885, respectively, is included in stock-based compensation expense-related party for the three and nine months ended June 30, 2025, and 2024, respectively. The Company valued the RM Warrant at $624,458 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $52,038 and $156,114, respectively, is included in stock-based compensation expense-related party for the three and nine months ended June 30, 2025, and 2024, respectively.

~~The~~Beginning ~~Company~~in ~~granted~~April ~~an option to SGG purchase 10~~2024,~~000,000~~ ~~shares of~~ the Company’s ~~common~~agreed stock at $0.02 per share with an expiry date of July 1, 2025 (the "CYCA Option”). The CYCA option vests at the rate of 25% beginning on the first six-month anniversary of the agreement, as well as a warrant to ~~purchase~~rent ~~250,000~~office ~~shares~~space offor the ~~Reticulate~~COO ~~Micro common stock the Company owns (the “RM Warrant”). The RM Warrant has an exercise price of $1.00 per share and an expiry date of July 1, 2025. The Company valued the CYCA Option~~ at $~~639~~2,~~543~~575 ~~based~~per onmonth ~~the~~plus ~~Black-Scholes~~incidental ~~option pricing method and will be amortized through the term of the agreement~~expenses, and accordingly, $53,295 and $106,590, respectively, is included in stock-based compensation expense-related party for the three and six months ended March 31, 2025, and 2024, respectively. The Company valued the RM Warrant at $624,458 based on ~~the~~a ~~Black-Scholes~~month ~~option~~to ~~pricing~~month ~~method and will be amortized through the term of the agreement~~basis, ~~and~~ accordingly, $528,~~038~~703 and $~~104~~24,~~076,~~613 ~~respectively,~~ is included in ~~stock-based~~ ~~compensation expense-~~related party expenses for the three and ~~six~~nine months ended ~~March~~June 3130, 2025~~, and 2024, respectively~~.

Beginning in April 2024, the Company agreed to rent office space for the COO at $2,575 per month plus incidental expenses, on a month to month basis, accordingly, $7,956 and $15,911 is included in related party expenses for the three and six months ended March 31, 2025.

Related party liabilities

As of ~~March~~June 3130, 2025, and September 30, 2024, the Company owes $~~403~~432,~~175~~371 and $413,093, respectively, to related parties as follows:

	March 31, 2025		September 30, 2024
	June 30, 2025		September 30, 2024
Management fees, Chief Executive Officer (CEO)	$	110,000	$	110,000
Bonus, CEO		48,040		68,040
Stock to be issued President and COO		~~245~~257,~~135~~960		208,635
Accounts payable, President and COO		-16,371		26,418
Total	$	~~403~~432,~~175~~371	$	413,093

NOTE 6 - CONVERTIBLE NOTES PAYABLE

During the quarter ended March 31, 2023, (the “March 2023 Notes”) the Company issued five (5) convertible promissory notes, in the aggregated principal amount of $160,000, to investors. The notes bear an interest rate of 18% per annum. Principal amount of $100,000 matured on July 1, 2024, and have been extended to July 1, 2025, while principal amount of $60,000 matured on various dates of February 2024 and were all extended to May 31, 2025. Interest payments are due quarterly. The Holders shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of Reticulate Micro (the “RM Stock”) owned by the Company. The notes are convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025, or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note. In conjunction with one note of $50,000, the Company issued a warrant to purchase 2,000,000 shares of common stock at an exercise price of $0.025 with an expiration date of July 1, 2025, and a warrant to purchase 100,000 shares of RM Stock at $1.00 per share with an expiry date of July 1, 2025. The warrants issued to purchase the Company’s common stock, and the RM Stock resulted in a debt discount of $43,416, with the offset to additional paid in capital. For the three and six months ended March 31, 2024, amortization of the debt discounts of $7,661 and $15,323 was charged to interest expense. In conjunction with one note of $50,000, the Company issued a warrant to purchase 2,000,000 shares of common stock at an exercise price of $0.025 with an expiration date of July 1, 2025, and a warrant to purchase 100,000 shares of RM Stock at $1.00 per share with an expiry date of July 1, 2025. The warrants issued to purchase the Company’s common stock, and the RM Stock resulted in a debt discount of $43,585, with the offset to additional paid in capital. For the three and six months ended March 31, 2024, amortization of the debt discounts of $7,691 and $15,383 was charged to interest expense. Both debt discounts were fully amortized as of September 30, 2024. During the six months ended March 31, 2025, $10,000 of principal notes and $1,670 of accrued interest were converted into 11,670 shares of RM stock. As of March 31, 2025, and September 30, 2024, the outstanding principal balance of the March 2023 Notes was $150,000 and $160,000, respectively.

Table of Contents

~~During~~NOTE the quarter ended December 31, 2023, (the “December 2023 Notes”) the Company issued a convertible promissory note of $40,000, to an investor. The note bears an interest rate of 18% per annum and matured during the quarter ended December 31, 2024, and has been extended to May 31, 2025. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of RM Stock owned by the Company beginning on the Issuance Date of the Company's common stock at $0.025 or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note. During the six months ended March 31, 2025, $40,000 of principal notes and $6~~,600~~ ~~of accrued interest were converted into 46,600 shares of RM stock. As of March 31, 2025, and September 30, 2024, there is a balance due of $~~-0- ~~and~~CONVERTIBLE ~~$40,000,~~NOTES ~~respectively, on the December 2023 Notes.~~PAYABLE

During the quarter ended March 31, ~~2024~~2023, (the “March ~~2024~~2023 Notes”) the Company issued ~~nine~~five (95) convertible promissory notes, in the ~~aggregate~~aggregated principal amount of $~~517~~160,~~500~~000, to investors. The notes bear an interest rate of 18% per annum. Principal amount of $100,000 matured on July 1, 2024, and ~~mature~~have ~~during~~been ~~the~~extended ~~quarter~~to ~~ended~~July ~~March~~1, 2025, while principal amount of $60,000 matured on various dates of February 2024 and were all extended to May 31, 2025. Interest payments are due quarterly. The ~~Holder~~Holders shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of Reticulate Micro (the “RM Stock”) owned by the Company. ~~beginning~~The onnotes ~~the~~are ~~Issuance~~convertible ~~Date~~into shares of the Company'’s common stock beginning on the Issuance Date at $0.025, or RM Stock at $21.00 per share,. ~~excluding~~The a note ofproceeds ~~$250,000~~will ~~which~~be ~~has~~used aby ~~conversion~~the ~~price~~Company offor general working capital purposes. The Company also agreed to pledge RM stock at $1.00 ofper RMshare ~~stock~~to ~~for~~equal the outstanding principal and ~~$2.50~~interest ofdue RMupon ~~stock~~any ~~for~~defaults ~~interest.~~of ~~The~~the note. ~~proceeds~~In ~~will~~conjunction bewith ~~used~~one bynote of $50,000, the Company ~~for~~issued ~~general~~a ~~working~~warrant ~~capital~~to ~~purposes~~purchase 2,000,000 shares of common stock at an exercise price of $0.025 ~~The~~with ~~Company~~an ~~also~~expiration ~~agreed~~date of July 1, 2025, and a warrant to ~~pledge~~purchase 100,000 shares of RM ~~stock~~Stock at $21.00 per share with an expiry date of July 1, 2025. The warrants issued to ~~equal~~purchase the ~~outstanding~~Company’s ~~principal~~common stock, and ~~interest~~the ~~due~~RM ~~upon~~Stock ~~any~~resulted ~~defaults~~in a debt discount of $43,416, with the ~~note~~offset to additional paid in capital. ~~During~~For the ~~year~~three and six months ended ~~September~~March 3031, 2024, amortization of the ~~lenders~~debt discounts of $~~167~~7,~~500~~661 and $15,323 was charged to interest expense. In conjunction with one note of $50,000, the ~~March~~Company ~~2024~~issued ~~Notes~~a ~~agreed~~warrant to ~~settle~~purchase ~~the~~2,000,000 ~~notes~~shares byof ~~the~~common ~~issuance~~stock at an exercise price of 83$0.025 with an expiration date of July 1,~~750~~ 2025, and a warrant to purchase 100,000 shares of RM Stock at $1.00 per share with an expiry date of July 1, 2025. The warrants issued to purchase the Company’s common stock, ~~for~~and the ~~principal~~RM ~~amount~~Stock resulted in a debt discount of $43,585, with the offset to additional paid in capital. For the three and nine months ended June 30, 2024, amortization of the debt discounts of $7,662 and $22,985 was charged to interest expense. Both debt discounts were fully amortized as of September 30, 2024. During the ~~six~~nine months ended ~~March~~June 3130, 2025, $~~350~~10,000 of principal notes and $591,~~575~~670 of accrued interest were converted into ~~352~~11,~~288~~670 shares of RM stock. As of ~~March~~June 3130, 2025, and September 30, 2024, ~~there~~the isoutstanding aprincipal balance of the March 2023 Notes was $~~-0-~~150,000 and $~~350~~160,000, respectively ~~on the March 2024 Notes~~.

During the quarter ended ~~June~~December 3031, ~~2024~~2023, (the “~~June~~December ~~2024~~2023 Notes”) the Company issued ~~thirty~~a ~~eight (38)~~ convertible promissory ~~notes~~note ~~in the aggregate~~ of $140,~~910~~000,~~950~~ to ~~investors~~an investor. The ~~notes~~note ~~bear~~bears an interest rate of 18% per annum and ~~mature~~matured during the quarter ~~ending~~ended ~~June~~December 3031, 2024, and has been extended to May 31, 2025. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of RM Stock owned by the Company beginning on the Issuance Date of the Company's common stock at $0.025 or RM Stock at $21.00 per share~~, excluding $85,000 of June 2024 Notes where the conversion price is $1~~.00 ~~for the RM stock and $15,000 of June 2024 Notes where the conversion price is $0.025 for the Company’s common stock.~~ The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $21.00 per share to equal the outstanding principal and interest due upon any defaults of the note. During the ~~year~~nine ~~ended September 30, 2024, the lenders of $1,147,000 of the June 2024 Notes agreed to settle the notes by the issuance of 573,500 shares of RM stock for the principal amount. During the six~~ months ended ~~March~~June 3130, 2025, $~~608~~40,000 of principal notes and $~~105~~6,~~395~~600 of accrued interest were converted into ~~400~~46,~~648~~600 shares of RM stock. As of ~~March~~June 3130, 2025, and September 30, 2024, there is a balance due of $~~155,950~~-0- and $~~763~~40,~~950~~000, respectively, ~~due~~ on the ~~June~~December ~~2024~~2023 Notes.

During the quarter ended ~~September~~March 3031, 2024, (the “~~September~~March 2024 Notes”) the Company issued ~~two~~nine (29) convertible promissory notes in the aggregate of $~~125~~517,~~000~~500, to investors. The notes bear an interest rate of 18% per annum and ~~mature~~matured during the quarter ended ~~September~~March 3031, 2025. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of RM Stock owned by the Company beginning on the Issuance Date of the Company's common stock at $0.025 or RM Stock at $2.00 per share, excluding a note of $250,000 which has a conversion price of $1.00 of RM stock for principal and $2.50 of RM stock for interest. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $2.00 per share to equal the outstanding principal and interest due upon any defaults of the note. During the ~~six~~year ended September 30, 2024, the lenders of $167,500 of the March 2024 Notes agreed to settle the notes by the issuance of 83,750 shares of RM stock for the principal amount. During the nine months ended ~~March~~June 3130, 2025, $~~125~~350,000 of principal notes and $2259,~~500~~575 of accrued interest were converted into 73 352,~~750~~288 shares of RM stock. As of ~~March~~June 3130, 2025, and September 30, 2024, there is a balance of $-0- and $~~125~~350,000, respectively, on the ~~September~~March 2024 Notes.

Table of Contents

During the quarter ended June 30, 2024, (the “June 2024 Notes”) the Company issued thirty eight (38) convertible promissory notes in the aggregate of $1,910,950 to investors. The ~~activity~~notes bear an interest rate of 18% per annum and mature during the quarter ending June 30, 2025. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of RM Stock owned by the Company beginning on the Issuance Date of the Company's common stock at $0.025 or RM Stock at $2.00 per share, excluding $85,000 of June 2024 Notes where the conversion price is $1.00 for the RM stock and $15,000 of June 2024 Notes where the conversion price is $0.025 for the Company’s common stock. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $2.00 per share to equal the outstanding principal and interest due upon any defaults of the note. During the year ended September 30, 2024, the lenders of $1,147,000 of the June 2024 Notes agreed to settle the notes by the issuance of 573,500 shares of RM stock for the principal amount. During the six months ended March 31, 2025, $608,000 of principal notes and ~~the~~$105,395 ~~year~~of ~~ended~~accrued interest were converted into 400,648 shares of RM stock. As of June 30, 2025, and September 30, 2024, there is ~~summarized~~a asbalance ~~follows:~~of $155,950 and $763,950, respectively, due on the June 2024 Notes.

	March 31, 2025			September 30, 2024
Beginning balance, face value	$	1,438,950		$	1,215,000
Convertible notes issued		-			2,593,450
Convertible notes converted		(1,133,000	)		(2,369,500	)
Ending balance	$	305,950		$	1,438,950

During the quarter ended September 30, 2024, (the “September 2024 Notes”) the Company issued two (2) convertible promissory notes in the aggregate of $125,000 to investors. The notes bear an interest rate of 18% per annum and mature during the quarter ended September 30, 2025. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of RM Stock owned by the Company beginning on the Issuance Date of the Company's common stock at $0.025 or RM Stock at $2.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $2.00 per share to equal the outstanding principal and interest due upon any defaults of the note. During the nine months ended June 30, 2025, $125,000 of principal notes and $22,500 of accrued interest were converted into 73,750 shares of RM stock. As of June 30, 2025, and September 30, 2024, there is a balance of $-0- and $125,000, respectively, on the September 2024 Notes.

The ~~Company~~activity ~~has~~for the ~~following~~nine ~~convertible~~months ~~notes~~ended ~~payable~~June ~~outstanding as of March 31~~30, 2025, and the year ended September 30, 2024, is summarized as follows:

	March 31,2025			September 30,2024
	June 30, 2025			September 30, 2024
March 2023 Convertible notes payable, interest at 18%, $60,000 matures May 31, 2025, and $100,000 matures July 1, 2025	$	150,000		$	160,000
Beginning balance, face value	$	1,438,950		$	1,215,000
December 2023 Convertible note payable, interest at 18%		-			40,000
Convertible notes issued		-			2,593,450
March 2024 Convertible notes payable, interest at 18%		-			350,000
Convertible notes converted		(1,133,000	)		(2,369,500	)
June 2024 Convertible notes payable, interest at 18%, matures during quarter ending June 30, 2025		155,950			763,950
Ending balance	$	305,950		$	1,438,950
September 2024 Convertible notes payable, interest at 18%		-			125,000
Convertible notes payable, balance	$	305,950		$	1,438,950

The Company has the following convertible notes payable outstanding as of June 30, 2025, and September 30, 2024:

	June 30, 2025		September 30, 2024
March 2023 Convertible notes payable, interest at 18%, $60,000 matured May 31, 2025, and $100,000 matures July 1, 2025	$	150,000	$	160,000
December 2023 Convertible note payable, interest at 18%		-		40,000
March 2024 Convertible notes payable, interest at 18%		-		350,000
June 2024 Convertible notes payable, interest at 18%, matured during quarter ending June 30, 2025		155,950		763,950
September 2024 Convertible notes payable, interest at 18%		-		125,000
Convertible notes payable, balance	$	305,950	$	1,438,950

NOTE 7 - CAPITAL STOCK

Common Stock

The Company has authorized 600,000,000 common shares, par value $0.001. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. As of ~~March~~June 3130, 2025, and September 30, 2024, there were 470,237,826 and 469,877,826, respectively, common shares issued and outstanding.

During the six months ended March 31, 2025, the following shares of common stock were issued:

· 360,000 shares of common issued for accrued interest, valued at $8,136.

During the six months ended March 31, 2024, the following shares of common stock were issued:

· On January 18, 2024, the Company issued 5,000,000 shares of common issued for services. The Company valued the shares at $104,000 based on the price of the common stock on the date the Company agreed to issue the shares. The shares were issued pursuant to a one-year consulting agreement beginning January 1, 2024. The company will amortize the value over the term of the contract. For the three and six months ended March 31, 2024, the Company recorded $26,000 of stock-based consulting expense. · On January 12, 2024, the Company issued 2,227,661 shares of common stock for payment of $55,124 of accounts payable and accrued interest. The value of the shares issued was $46,336 based upon the share price of the Company’s common stock on the date the Company agreed to issue the common stock. The Company recorded an $8,788 gain on debt extinguishment for the three and six months ended January 31, 2024. · On December 14, 2023, the Company issued 6,000,000 shares of common issued for services. The Company valued the shares at $169,200 based on the price of the common stock on the date the Company agreed to issue the shares and is included in stock-based consulting expense for the six months ended March 31, 2024. · On November 30, 2023, the Company issued 1,887,750 shares issued for payment of $46,826 of accounts payable and accrued interest. The value of the shares issued was $50,781 based upon the share price of the Company’s common stock on the date the Company agreed to issue the common stock. The Company included $3,955 in loss on debt extinguishment for the six months ended March 31, 2024.

Table of Contents

During the nine months ended June 30, 2025, the following shares of common stock were issued:

360,000 shares of common issued for accrued interest, valued at $8,136.

Preferred Stock

The Company has 100,000,000 shares authorized as preferred stock, par value $0.001 (the “Preferred Stock”), which such Preferred Stock shall be issuable in such series, and with such designations, rights and preferences as the Board of Directors may determine from time to time.

Series A Preferred Stock

On March 3, 2025, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company’s Series A Preferred Stock. Under the terms of the Amendment to Certificate of Designation of Series A Preferred Stock, 10,000,000 shares of the Company’s preferred shares are designated as Series A Preferred Stock. Each share of Series A Preferred Stock is convertible into one hundred shares of fully paid and non-assessable Common Stock. For so long as any shares of the Series A Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to one hundred shares for each share of Series A Preferred Stock held. As of June 30, 2025, there were -0- shares of Series A Preferred Stock issued and outstanding.

Series C Preferred Stock

Under the terms of the Certificate of Designation of Series C Preferred Stock, 12,000,000 shares of the Company’s preferred shares are designated as Series C Preferred Stock. Each share of Series C Preferred Stock is convertible into one hundred shares of Common Stock, and each share of Series C Preferred Stock is entitled to one hundred votes. As of ~~March~~June 3130, 2025, and September 30, 2024, there were 600,000 shares of Series C Preferred Stock issued and outstanding.

Series D Preferred Stock

On September 30, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company’s Series D Preferred Stock. Under the terms of the Amendment to Certificate of Designation of Series D Preferred Stock, 10,000,000 shares of the Company’s preferred shares are designated as Series D Preferred Stock. Each share of Series D Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock. For so long as any shares of the Series D Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to two times the sum of all the number of shares of other classes of Corporation capital stock eligible to vote on all matters submitted to a vote of the stockholders of the Corporation. As of ~~March~~June 3130, 2025, and September 30, 2024, there were 50,000 shares of Series D Preferred Stock issued and outstanding.

Series E Preferred Stock

On June 2, 2021, the Company filed a Certificate of Designation with the State of Nevada. Under the terms of the Certificate of Designation 13,650,000 (as amended on June 10, 2021) were designated as Series E Preferred Stock. Each share of Series E Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock. For so long as any shares of the Series E Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote one share on all matters submitted to a vote of the stockholders of the Corporation. As of ~~March~~June 3130, 2025, and September 30, 2024, there were no shares of Series E Preferred stock issued and outstanding.

Series F Preferred Stock

On November 24, 2021, the Company filed a Certificate of Designation with the State of Nevada. Under the terms of the Certificate of Designation 59,270,000 were designated as Series F Preferred Stock. Each share of Series F Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock at any time by the holder. For so long as any shares of the Series F Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote one share on all matters submitted to a vote of the stockholders of the Corporation. The Series F Preferred Stock automatically converts to common stock after the shares of common stock closing market price is at least $0.20 for twenty (20) consecutive trading days. As of ~~March~~June 3130, 2025, and September 30, 2024, there were no shares of Series F Preferred stock issued and outstanding.

Stock Options

The Company did not issue any stock options during the ~~six~~nine months ended ~~March~~June 3130, 2025.

On February 1, 2023, pursuant to a three-year consulting agreement, the Company granted an option to SGG (a related party, the representative of which is the Company’s COO ) to purchase 10,000,000 shares of common stock with an exercise price of $0.02 and an expiration date of July 1, 2025. The options vest over a two-year period at the rate of 25% every six months beginning on the six-month anniversary date of the agreement. The Company valued the option at $639,543 and will amortize the value over the three-year term of the agreement. As of June 30, 2025, 10,000,000 options have vested.

Table of Contents

On ~~February~~March 13, 2023, pursuant to a ~~three~~one-year consulting agreement, the Company granted an option to ~~SGG (~~a ~~related~~third party, ~~the representative of which is the Company’s COO )~~ to purchase 10,000,000 shares of common stock with an exercise price of $0.02 and an expiration date of July 1, 2025. The options vest over a two-year period at the rate of 25% every six months beginning on the six-month anniversary date of the agreement. The Company valued the option at $~~639~~449,~~543~~651 and ~~will~~amortized ~~amortize~~ the value over the ~~three~~one-year term of the agreement. As of ~~March~~June 3130, 2025, 10,000,000 options have vested.

OnThe ~~March~~following 3,table ~~2023,~~summarizes ~~pursuant~~activities torelated ~~a one-year consulting agreement, the Company granted an option~~ to ~~a third party to purchase 10,000,000 shares of common~~ stock ~~with an exercise price of $0.02 and an expiration date of July 1, 2025. The~~ options ~~vest over a two-year period at the rate~~ of ~~25% every six months beginning on~~ the ~~six-month~~Company ~~anniversary~~for ~~date of~~ the ~~agreement.~~nine ~~The~~months ~~Company~~ended ~~valued~~June ~~the~~30, ~~option at $449~~2025,~~651~~ and ~~amortized~~ the ~~value over the one-~~year ~~term~~ended ofSeptember ~~the agreement. As of March 31~~30, ~~2025, 10,000,000 options have vested~~2024.

The following table summarizes activities related to stock options of the Company for the six months ended March 31, 2025, and the year ended September 30, 2024.

	Number of Options		Weighted- Average Exercise Price per Share		Weighted- Average Remaining Life (Years)
Outstanding at October 1, 2023		20,000,000	$	0.02		1.75
Outstanding at September 30, 2024		20,000,000	$	0.02		0.75
Exercisable at September 30, 2024		15,000,000	$	0.02		-
Outstanding at June 30, 2025		20,000,000	$	0.02		0.00
Exercisable at June 30, 2025		20,000,000	$	0.02		-

	Number ofOptions		Weighted- Average Exercise Priceper Share		Weighted- Average Remaining Life (Years)
Outstanding at October 1, 2023		20,000,000	$	0.02		1.75
Outstanding at September 30, 2024		20,000,000	$	0.02		0.75
Exercisable at September 30, 2024		15,000,000	$	0.02		-
Outstanding at March 31, 2025		20,000,000	$	0.02		0.25
Exercisable at March 31, 2025		20,000,000	$	0.02		-

As of June 30, 2025, and September 30, 2024, -0- and 5,000,000 options to purchase shares of common stock remain unvested and $-0- and $284,241, respectively, of stock compensation expense remains unrecognized and is being expensed over a weighted average period of 2.37 years from the date of the grant.

As of March 31, 2025, and September 30, 2024, -0- and 5,000,000 options to purchase shares of common stock remain unvested and $177,651 and $284,241, respectively, of stock compensation expense remains unrecognized and is being expensed over a weighted average period of 2.37 years from the date of the grant.

Warrants

On April 1, 2024, pursuant to a consulting agreement, the Company issued a warrant to a third party to purchase 50,000 shares of RM Stock that vested immediately and with an exercise price of $1.50 and an expiration date of April 1, 2025. The Company valued the warrant at $119,348 based on the Black Scholes option pricing model and expensed when granted. The following assumptions were utilized in the Black-Scholes valuation of this immediately vested warrant during the year ended September 30, 2024, risk free interest rate of 5.03%, volatility of 145% and an exercise price of $1.50.

On February 1, 2023, pursuant to a three-year consulting agreement, the Company granted a warrant to a related party (SGG) to purchase 250,000 shares of RM common stock with an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the warrant at $624,458 and will amortize the value over the three-year term of the agreement. For the three and ~~six~~nine months ended ~~March~~June 3130, 2025, and 2024, the Company has included $52,038 and $~~104~~156,~~076~~114 in stock-based compensation expense-related party, respectively.

On February 8, 2023, an investor paid $5,000 to acquire a warrant to purchase 2,000,000 shares of common stock. The warrant has an exercise price of $0.02 per share and expires July 1, 2024. The Company also issued a warrant to purchase 100,000 shares of RM Stock, with an exercise price of $1.00 and an expiration date of July 1, 2025, as amended.

On February 10, 2023, pursuant to a convertible note with a current shareholder of the Company, the Company issued a warrant to the investor to purchase 2,000,000 shares of common stock at an exercise price of $0.025 per share and an expiration date of July 1, 2025. The Company valued the warrant at $79,914, based on the Black Scholes option pricing model. The Company also issued a warrant to purchase 100,000 shares of RM Stock at an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the RM Stock warrant at $249,811, based on the Black Scholes option pricing model. The Company applied $43,416 to the note as a discount based on the allocations of the fair values of the warrants and the note. The Company charged the note discount to interest expense over the term of the note. For the three and ~~six~~nine months ended ~~March~~June 3130, 2024, the Company recorded interest expense of $7,~~661~~662 and $1522,~~323~~985, respectively. The note discount was fully amortized as of September 30, 2024.

Table of Contents

On March 1, 2023, an investor paid $5,000 to acquire a warrant to purchase 2,000,000 shares of common stock. The warrant has an exercise price of $0.02 per share and expires July 1, 2024. The Company also issued a warrant to purchase 100,000 shares of RM Stock, with an exercise price of $1.00 and an expiration date of July 1, 2025, as amended.

On March 3, 2023, pursuant to a convertible note with a current shareholder of the Company, the Company issued a warrant to the investor to purchase 2,000,000 shares of common stock at an exercise price of $0.025 per share and an expiration date of July 1, 2025. The Company valued the warrant at $89,916, based on the Black Scholes option pricing model. The Company also issued a warrant to purchase 100,000 shares of RM Stock at an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the RM Stock warrant at $249,822, based on the Black Scholes option pricing model. The Company applied $43,585 to the note as a discount based on the allocations of the fair values of the warrants and the note. The Company charged the note discount to interest expense over the term of the note. For the three and ~~six~~nine months ended ~~March~~June 3130, 2024, the Company recorded interest expenses of $7,~~691~~692 and $1523,~~383~~075, respectively. The note discount was fully amortized as of September 30, 2024.

On March 3, 2023, pursuant to a one-year consulting agreement with a Company shareholder, the Company issued to the shareholder a warrant to purchase 250,000 shares of RM Stock with an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the warrant at $624,556 and amortized the value over the one-year term of the agreement. For the three and ~~six~~nine months ended ~~March~~June 3130, 2024, the Company has included $~~104,093~~-0- and $260,232, respectively, in general and administrative expenses. The warrant value was fully amortized as of September 30, 2024.

The following table summarizes activities related to warrants of the Company for the ~~six~~nine months ended ~~March~~June 3130, 2025, and the year ended September 30, 2024.

	Number of Warrants			Weighted Average Exercise Price Per Share		Weighted Average Remining Life (Years)
Outstanding and exercisable at October 1, 2023		8,000,000		$	0.0225		1.25
Expired or cancelled or forfeited		(4,000,000	)		0.0200		-
Outstanding and exercisable at September 30, 2024		4,000,000		$	0.0250		0.75
Outstanding and exercisable at March 31, 2025		4,000,000		$	0.0250		0.25
Outstanding and exercisable at June 30, 2025		4,000,000		$	0.0250		0.00

The following table summarizes activities related to warrants to purchase RM Stock from the Company for ~~six~~nine months ended ~~March~~June 3130, 2025, and the year ended September 30, 2024.

	Number of Warrants		Weighted Average Exercise Price Per Share		Weighted Average Remining Life (Years)
Outstanding and exercisable at October 1, 2023		900,000	$	1.00		1.53
Issued		50,000		1.50		1.00
Outstanding and exercisable at September 30, 2024		950,000	$	1.03		0.74
Outstanding and exercisable at March 31, 2025		950,000	$	1.03		0.24
Outstanding and exercisable at June 30, 2025		950,000	$	1.03		0.00

Table of Contents

NOTE 8 - COMMITMENTS AND CONTINGENCIES

The Company does not have an existing contract with the CEO. The monthly compensation and any bonus amounts are at the discretion of the Board of Directors. Effective January 1, 2023, the Company agreed to compensate the CEO $15,000 per month.

Effective February 1, 2023, the Company entered a Consulting Executive Officer Agreement with a three- year term to an entity (SGG) to provide the services of a Chief Operating Officer (the “COO”) of the Company. On October 1, 2023, the BOD also appointed the COO as the President. Pursuant to the agreement, the Company agreed to a monthly fee of $10,000, and the issuance of 250,000 common shares per month, to be issued semi-annually. The monthly fee was increased to $15,000 per month effective September 1, 2023. For the three ~~months~~ and ~~six~~nine months ended ~~January~~June 3130, 2025, the Company recorded expenses of $1812,~~050~~825 and $3649,~~500~~326, respectively, and $2119,~~500~~375 and $3958,~~375~~751, respectively, for the three and ~~six~~nine months ended ~~March~~June 3130, 2024, related to the 250,000 common shares per month, calculated based on the closing market price of the common stock on the last day of each month.

On May 8, 2024, the Company issued 3,000,000 shares of common stock for the months of February 2023, through January 2024. On May 11, 2023, the Company issued 5,000,000 shares to the Company’s COO as a bonus pursuant to their Consulting Agreement. On July 10, 2023, the Company issued 15,000,000 shares to the Company’s COO as a bonus pursuant to their Consulting Agreement. On September 7, 2023, the Company issued 5,000,000 shares to the Company’s COO as a bonus pursuant to their Consulting Agreement.

Additionally, the Company granted an option to SGG, a related party (the representative of which is the Company’s COO), to purchase 10,000,000 shares of the Company’s common stock at $0.02 per share with an expiry date of July 1, 2025 (the "CYCA Option”). The CYCA option vests at the rate of 25% beginning on the first six-month anniversary of the agreement, as well as a warrant to purchase 250,000 shares of the Reticulate Micro common stock the Company owns (the “RM Warrant”). The RM Warrant has an exercise price of $1.00 per share and an expiry date of July 1, 2025. The Company valued the CYCA Option at $639,543 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $53,295 and $~~106~~159,~~590~~885, respectively, is included in stock-based compensation expense-related party for the three and ~~six~~nine months ended ~~March~~June 3130, 2025, and 2024, respectively. The Company valued the RM Warrant at $624,458 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $52,038 and $~~104~~156,~~076~~114, respectively, is included in stock-based compensation expense-related party for the three and ~~six~~nine months ended ~~March~~June 3130, 2025, and 2024, respectively.

On March 3, 2023, the Company entered a Consulting Agreement with an investor. Pursuant to the agreement, the Company issued 2,000,000 shares of common stock for one year of services. The Company valued the shares at $80,000 based on the price of the common stock on the date the Company agreed to issue the common stock. The Company also issued the consultant 1) an option to purchase 10,000,000 shares of the Company’s common stock at an exercise price of $0.02 per share with an expiry date of July 1, 2025. The options vest over the two-year period in 25% increments beginning on the six- month anniversary of the agreement and 2) a warrant to purchase 250,000 shares of RM Stock at an exercise price of $1.00 per share with an expiry date of July 1, 2025. The option to purchase the Company’s common stock was valued at $449,651 based on the Black Scholes option pricing model and was amortized over the one-year term of the agreement. For the three and ~~six~~nine months ended ~~March~~June 3130, 2024, $74,942, and $187,355 is included in stock-based compensation expense, respectively, and this option value was fully amortized as of September 30, 2024. The warrant to purchase the RM Stock was valued at $624,556 based on the Black Scholes option pricing model and was amortized over the one-year term of the agreement. For the three and ~~six~~nine months ended ~~March~~June 3130, 2024, $~~104,093~~-0- and $260,232 is included in stock-based compensation expense, respectively. and this warrant value was fully amortized as of September 30, 2024. On December 6, 2023, the Company agreed to issue an additional 6,000,000 shares of common stock. The Company valued the 6,000,000 shares at $0.0282 per share and included stock-based compensation expense of $169,200 for the ~~six~~nine months ended ~~March~~June 3130, 2024. On May 16, 2024, the Company agreed to issue an additional 2,500,000 shares of common stock. The Company valued the 2,500,000 shares at $0.03 per share and included stock-based compensation expense of $75,000 for the three and nine months ended June 30, 2024.

On April 1, 2023, the Company entered a Consulting Agreement with a third party for marketing services in exchange for 250,000 shares of restricted common stock. The shares vest in 12 equal amounts of 20,833. For the three and ~~six~~nine months ended ~~March~~June 3130, 2024, the Company has recorded stock-based compensation of $~~3,006~~-0- and $6,012, respectively, with the offset to accounts payable and accrued expenses.

Table of Contents

On October 1, 2023, the Company entered into a one-year Agreement for Board of Advisor Services with a third party to provide general technical, AI, sales, and marketing services in exchange for 3,000,000 shares of common stock. The Company valued the shares at $80,700 ($0.0269 per share). The shares are to be issued at the end of the term, and the Company is amortizing the expense over the term of the contract. For the three and ~~six~~nine months ended ~~March~~June 3130, 2024, the Company included $20,175 and $4060,~~350~~525, respectively, in General and Administrative expenses and in accounts payable and accrued expenses. Effective May 1, 2024, the Company amended the October 1, 2023, agreement and agreed to issue 7,000,000 shares, of which 5,000,000 were immediately earned and were issued May 16, 2024, and to issue an additional 2,000,000 shares at the end of the term. The Company valued and expensed the 5,000,000 shares at $142,500 ($0.0285 per share) on the date of the agreement, and the Company is amortizing the expense related to the 2,000,000 shares (valued at $57,000) over the term of the contract. For the three and ~~six~~nine months ended ~~March~~June 3130, 2025, the Company included $144,~~250~~750 and $2833,~~500~~250 in General and Administrative expenses and $5257,~~250~~000 in accounts payable and accrued expenses.

On January 1, 2024, the Company entered into a one-year Consulting Agreement with a third party to provide market awareness services and the identification, evaluation, structuring, negotiating, and closing of joint ventures, strategic alliances, and business acquisitions, in exchange for 3,000,000 shares of common stock. The Company valued the shares at $62,400 and is amortizing the expense over the term of the contract. For the ~~six~~nine months ended ~~March~~June 3130, 2025, the Company included $15,600 in General and Administrative expenses.

On January 2, 2024, the Company entered into a one-year Consulting Agreement with a third party to provide market awareness services and the identification, evaluation, structuring, negotiating, and closing of joint ventures, strategic alliances, and business acquisitions, in exchange for a monthly fee of $10,000 per month and 5,000,000 shares of common stock. The shares were issued on January 18, 2024. The Company valued the shares at $104,000 and is amortizing the expense over the term of the contract. For the ~~six~~nine months ended ~~March~~June 3130, 2025, the Company included $26,000 in General and Administrative expenses.

On April 1, 2024, the Company entered an Agreement for Board of Advisor Services with a third party to provide general business, military, governmental, technical, AI, and sales and marketing services, in exchange for 2,500,000 shares of common stock upon execution of the agreement (the “Initial Issuance”) and a further 2,500,000 shares of common stock one year after the execution (the “Final Issuance”). The Initial Issuance of 2,500,000 shares of common stock were issued on May 8, 2024. The Company valued the 5,000,000 shares at $137,500 among which $68,750 related to Initial Issuance and is amortizing over the term of the contract. For the ~~three~~nine ~~and six~~ months ended ~~March~~June 3130, 2025, the Company included $68,~~750in~~750 in General and Administrative expenses, including the amortization of prepaid expenses of $34,375 (Initial Issuance) and $34,375 accrued in accounts payable and accrued expenses (Final Issuance). In connection with the agreement, the Company also agreed to issue a warrant to purchase 50,000 Class A common stock shares of RM Stock owned by the Company, at $1.50 per share and vested immediately. The warrant to purchase the RM Stock was valued at $119,348 based on the Black Scholes option pricing model and was expensed when granted.

On April 23, 2024, the Company entered an Agreement for Board of Advisor Services with a third party to provide assistance to the Company in building its in house development team and manage software projects, in exchange for 3,000,000 shares of common stock. The Company issued 1,500,000 shares of common stock on May 8, 2024, with the balance due on the one-year anniversary of the agreement. The Company valued the 3,000,000 shares at $67,500 among which $33,750 related to the already issued common shares and is amortizing over the term of the contract. For the ~~three~~nine ~~and six~~ months ended ~~March~~June 3130, 2025, the Company included $~~16,875 and $~~33,750, ~~respectively,~~ in General and Administrative expenses, including the amortization of prepaid expenses of $16,875 and $16,875 accrued in accounts payable and accrued expenses.

On April 23, 2024, the Company entered an Agreement for Board of Advisor Services with a third party to provide general business, military, governmental, technical, AI, and sales and marketing services, in exchange for 5,000,000 shares of common stock. The Company issued 2,500,000 shares of common stock on May 8, 2024, with the balance due on the one-year anniversary of the agreement. The Company valued the 5,000,000 shares at $112,500 among which $56,250 relates to the already issued common shares and is amortizing over the term of the contract. For the ~~three~~nine ~~and six~~ months ended ~~March~~June 3130, 2025, the Company included $~~28,125 and $~~56,250, ~~respectively,~~ in General and Administrative expenses, including the amortization of prepaid expenses of $28,125 and $28,125 accrued in accounts payable and accrued expenses.

Table of Contents

NOTE 9 - LICENSE AGREEMENT

On August 9, 2022, the Company signed an Intellectual Property License Agreement (the “IPLA”) with Reticulate Micro, Inc. (“RM”). Pursuant to the ten-year term (the “Term”) of IPLA, RM agreed to issue to the Company 5,100,000 shares of RM’s Class A Common Stock and a royalty of 5% of net sales during the Term in exchange for the licensing of the Company’s technology related to its SUPR ISR (the Superior Utilization of Processing Resources- Intelligence, Surveillance and Reconnaissance).

RM, a Nevada corporation, was formed on June 22, ~~Table~~2022. Mr. Collins, the Company’s’ former CTO was a co-founder, and a former Director and President and Treasurer of ~~Contents~~RM. Mr. Chermak, the Company’s former COO is a co-founder, Director and Vice-president and Secretary of RM. Mr. Ansari is a co-founder and former Director of RM. RM had initially issued 1,600,000, 1,000,000 and 1,000,000 shares of Class B Common Stock to Mr. Collins. Mr. Chermak and Mr. Ansari, respectively. On May 15, 2023, Mr. Collins cancelled his 1,600,000 shares of Class B common stock in exchange for 200,000 shares of Class A common stock. As of June 30, 2025, and September 30, 2024, RM has 2,000,000 and 2,000,000 Class B Common Stock shares are outstanding, respectively. Each share of the Class B Common Stock has voting rights whereby each share of Class B Common Stock equals 100 voting shares. As of June 30, 2025, and September 30, 2024, RM had 19,778,946 and 10,459,199 Class A common stock shares issued and outstanding, respectively. As of June 30, 2025, the Company has issued 2,620,486 shares of RM stock in satisfaction of $3,502,500 of principal of convertible notes and $280,627 of accrued interest. The Company also issued 45,000 shares of RM stock in satisfaction of note payable (principal and interest). Accordingly, as of June 30, 2025, and September 30, 2024, the Company’s 2,434,514 and 3,319,469 shares, respectively, of RM Class A Common Stock represents approximately 1.11% and 1.57%, respectively of the voting stock of RM. Each share of the Class B Common stock is also convertible into one share of Class A Common Stock.

~~RM,~~The ~~a Nevada corporation, was formed on June 22, 2022. Mr. Collins, the~~ Company~~’s’~~ ~~former~~initially ~~CTO~~accounted ~~was~~for aits ~~co-founder,~~interest ~~and~~in ~~a former Director and President and Treasurer of~~ RM. ~~Mr.~~under ~~Chermak,~~ the ~~Company’s~~cost ~~former~~method ~~COO is a co-founder, Director and Vice-president and Secretary~~ of RMaccounting. ~~Mr.~~On ~~Ansari~~January ~~is a co-founder and former Director of RM. RM had initially issued 1~~30,~~600,000,~~ 12025,~~000,000~~ ~~and~~the ~~1,000,000~~Company ~~shares~~pursuant ofto ~~Class~~ASC B321 was ~~Common~~able ~~Stock~~ to ~~Mr.~~identify ~~Collins.~~observable ~~Mr.~~price ~~Chermak~~changes ~~and~~in ~~Mr.~~orderly ~~Ansari,~~transactions ~~respectively.~~for Onthe ~~May~~identical ~~15,~~or ~~2023,~~a ~~Mr.~~similar ~~Collins~~investment ~~cancelled his 1,600,000 shares~~ of ~~Class~~the Bsame ~~common stock in exchange for 200,000 shares of Class A common stock~~issuer. ~~As of March 31~~Accordingly, ~~2025,~~Company ~~and~~began ~~September~~to ~~30,~~measure ~~2024,~~its RMequity ~~has~~investment ~~2,000,000~~at ~~and~~fair ~~2,000,000~~value ~~Class~~in Baccordance ~~Common~~with ~~Stock~~ASC ~~shares~~820 ~~are~~as ~~outstanding, respectively. Each share~~ of the ~~Class~~date Bthat ~~Common~~the ~~Stock~~observable ~~has~~transaction ~~voting rights whereby each share of Class B Common Stock equals 100 voting shares~~occurred. ~~As of March 31, 2025, and September 30, 2024, RM had 10,479,431 and 10,459,199 Class~~ A ~~common~~separate ~~stock~~election ~~shares~~to ~~issued~~use ~~and outstanding, respectively. As of March 31, 2025,~~ the ~~Company~~alternative ~~has~~needs ~~issued 2,620,486 shares~~to ofbe RMmade ~~stock~~for ineach ~~satisfaction~~eligible ofinvestment ~~$3,502,500 of principal of convertible notes~~ and ~~$280,627 of~~the ~~accrued~~alternative ~~interest.~~should ~~The~~be ~~Company~~applied ~~also~~consistently ~~issued~~from ~~45,000~~period ~~shares~~to ofperiod RMuntil ~~stock in satisfaction of note payable (principal and interest). Accordingly, as of March 31, 2025, and September 30, 2024,~~ the ~~Company~~investment’s ~~2,416,278~~fair ~~and~~value ~~3,319,469~~becomes ~~shares,~~readily ~~respectively,~~determinable. ~~of RM~~Entities ~~Class~~are Aalso ~~Common~~required ~~Stock~~to ~~represent~~reassess ~~approximately~~at ~~1.15%~~each ~~and~~reporting ~~1.57%,~~period ~~respectively~~whether ofan ~~the~~investment ~~voting~~qualifies ~~stock~~for ~~of RM. Each share of~~ the ~~Class B Common stock is also convertible into one share of Class A Common Stock~~alternative.

~~The~~From January 1, 2025, through January 29, 2025, the Company ~~initially~~issued ~~accounted~~654,860 ~~for~~shares ~~its~~of ~~interest~~RM stock in RMsettlement ~~under~~of ~~the~~$803,000 ~~cost~~of ~~method~~principal and $138,175 of ~~accounting.~~accrued ~~Durin~~interest ~~the~~on ~~quarter~~convertible ~~ending~~notes. ~~March~~On 31January 30, 2025, the Company ~~pursuant~~recorded tothe ~~ASC~~initial ~~321 was~~fair ~~able~~value of the 2,664,609 shares at $9,992,284 the initial value) to ~~identify~~marketable ~~observable~~securities ~~price~~at ~~changes~~fair invalue, ~~orderly~~based ~~transactions~~on ~~for~~$3.75 per share (the ~~identical~~opening orprice aof ~~similar~~RM ~~investment~~on ofOTC Markets with the ~~same~~offset ~~issuer~~to unrealized gain on marketable securities). ~~Accordingly~~From January 30, 2025, through June 30, 2025, the Company ~~began~~issued to230,095 ~~measure~~shares ~~its~~of ~~equity~~RM ~~investment~~Class atA ~~fair~~Common ~~value~~Stock in ~~accordance~~settlement ~~with~~of ~~ASC~~$330,000 ~~820~~of asprincipal and $54,820 of accrued interest on convertible notes and recorded a loss on the ~~date~~issuances ~~that~~of the ~~observable~~shares ~~transaction~~of ~~occurred. A~~$787,637 ~~separate~~which ~~election~~is included toin ~~use~~loss ~~the~~on ~~alternative~~settlement ~~needs~~of todebt bein ~~made~~other income (expense), in its Statements of Operations for ~~each~~the ~~eligible~~nine ~~investment~~months ended June 30, 2025. The Company also recorded a net unrealized loss of $1,742,138 and a net unrealized gain of $5,919,760 for the ~~alternative~~three ~~should~~and benine ~~applied~~months ~~consistently~~ended ~~from~~June ~~period~~30, to2025, ~~period~~respectively, ~~until~~based on the ~~investment’s~~changes in fair value ~~becomes~~during ~~readily~~the ~~determinable~~three and nine months ended June 30, 2025. ~~Entities~~As ~~are~~of ~~also~~June ~~required~~30, to2025, ~~reassess~~the marketable securities at ~~each~~fair ~~reporting~~value ~~period~~are ~~whether~~$4,747,302 anand ~~investment~~are ~~qualifies~~included ~~for~~in current assets on the ~~alternative.~~balance sheet.

From January 1, 2025, through January 29, 2025, the Company issued 654,860 shares of RM stock in settlement of $803,000 of principal and $138,175 of accrued interest on convertible notes. On January 30, 2025, the Company recorded the initial fair value of the 2,664,609 shares at $9,992,284 the initial value) to marketable securities at fiar value, based on $3.75 per share (the opening price of RM on OTC Markets with the offset to unrealized gain on marketable securities). From January 30, 2025, through March 31, 2025, the Company issued 230,095 shares of RM Class A Common Stock in settlement of $330,000 of principal and $54,820 of accrued interest on convertible notes and recorded a loss on the issuances of the shares of $787,637 which is included in realized losses on its available-for-sale securities in other income (expense), in its Statements of Operations for the three and six months ended March 31, 2025. The Company also recorded net unrealized losses of $2,330,386 for the three and six months ended March 31, 2025, based on the changes in fair value during the three months ended March 31, 2025, reducing the initial value. As of March 31, 2025, the marketable securities at fair value are $6,489,441 and are included in current assets on the balance sheet, and an unrealized gain of $7,661,898, is included Other Income.

NOTE 10 - INCOME TAXES

The Company provides for income taxes under ASC 740, Accounting for Income Taxes. ASC 740 requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. ASC 740 requires the reduction of deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized.

In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to allow for the realization of deferred tax assets. Based upon the historical and anticipated future income, management has determined that the deferred tax assets do not meet the more-likely-than-not threshold for realizability. Accordingly, there is a full valuation allowance provided against the Company’s deferred tax assets as of March 31, 2025, and September 30, 2024.

Table of Contents

A reconciliation of the provision for income taxes determined at the U.S. statutory rate to the Company’s effective income tax rate is as follows:

	Six months ended March 31,2025			Six months Ended March 31,2024
	Nine months ended June 30, 2025			Nine months Ended June 30, 2024
Pre-tax income (loss)	$	53,~~497~~368,~~681~~421		$	(23,~~047~~501,~~669~~466	)
U.S. federal corporate income tax rate		21	%		21	%
Expected U.S. income tax (credit)		1707,~~154,513~~368			(~~430~~735,~~010~~308	)
Permanent differences		(1,~~509~~117,~~034~~374	)		~~208~~355,~~328~~294
Change of valuation allowance		~~354~~410,~~521~~006			~~281~~380,~~682~~014
Effective tax expense	$	—		$	—

The Company had deferred tax assets as follows:

	March 31, 2025			September 30, 2024
	June 30, 2025			September 30, 2024
Net operating losses carried forward	$	2,~~799~~855,~~871~~356		$	2,~~445~~353,~~350~~239
Less: Valuation allowance		(2,~~799~~855,~~871~~356	)		(2,~~445~~353,~~350~~239	)
Net deferred tax assets	$	—		$	—

As of ~~March~~June 3130, 2025, and September 30, 2024, the Company has approximately $13,~~332~~596,000 and $11,645,000, respectively, net operating loss carryforwards available to reduce future taxable income. As of ~~March~~June 3130, 2025, and September 30, 2024, the Company has no material unrecognized tax benefits which would favorably affect the effective income tax rate in future periods and does not believe that there will be any significant increases or decreases of unrecognized tax benefits within the next twelve months. No interest or penalties relating to income tax matters have been imposed on the Company during the three and ~~six~~nine months ended ~~March~~June 3130, 2025, and 2024, and no provision for interest and penalties is deemed necessary as of ~~March~~June 3130, 2025, and September 30, 2024.

NOTE 11 - DEFERRED REVENUE

The Company records the agreed amounts over the one-year term of the subscription agreements as deferred revenue, classified as a liability on the balance sheet, and amortizes the deferred revenue over the subscription period. For the three and ~~six~~nine months ended ~~March~~June 3130, 2025, the Company recognized $~~1,249~~416 and $2,~~498~~914, respectively, compared to $0832 and $23,~~411~~243 for the three and ~~six~~nine months ended ~~March~~June 3130, 2024, respectively, of revenue from these agreements. As of ~~March~~June 3130, 2025, there ~~remains~~is ~~$416~~no of deferred revenue.

NOTE 12 - SUBSEQUENT EVENTS

On August 27, 2025, the Company transferred 100,000 shares of RM stock in satisfaction of $100,000 of principal of convertible notes.

From September 8, 2024, through October 28, 2025, the Company sold 822,337 shares of the RM stock it owned for $625,500.

On October 14, 2025, the Company agreed to transfer, and 2 individuals agreed to accept 150,000 shares of RM stock in the aggregate, in satisfaction of shares of Company common stock the Company owed to the individuals.

On October 15, 2025, the Company issued 10,000,000 shares of common stock, valued at $220,000 ($0.022 per share, the market price on the date of the agreement) to an existing shareholder, pursuant to a consulting agreement.

The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no other such events that warrant disclosure or recognition in the financial statements.

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following is management’s discussion and analysis of certain significant factors that have affected our financial position and operating results during the periods included in the accompanying consolidated financial statements, as well as information relating to the plans of our current management. This report includes forward-looking statements. Generally, the words “believes,” “anticipates,” “may,” “will,” “should,” “expect,” “intend,” “estimate,” “continue,” and similar expressions or the negative thereof or comparable terminology are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, including the matters set forth in this report or other reports or documents we file with the Securities and Exchange Commission from time to time, which could cause actual results or outcomes to differ materially from those projected. Undue reliance should not be placed on these forward -looking statements which speak only as of the date hereof. We undertake no obligation to update these forward-looking statements.

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, the Company cannot guarantee future results, levels of activity, performance, or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). These accounting principles require us to make certain estimates, judgments, and assumptions. We believe that the estimates, judgments, and assumptions upon which we rely are reasonable based upon information available to us at the time that these estimates, judgments, and assumptions are made. These estimates, judgments, and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Our financial statements would be affected to the extent there are material differences between these estimates.

The following discussion should be read in conjunction with our unaudited financial statements and the related notes that appear elsewhere in this Quarterly Report on Form 10-Q.

THE COMPANY

Results of Operations for the three and ~~six~~nine months ended ~~March~~June 3130, 2025, and 2024:

Revenues for the three and ~~six~~nine months ended ~~March~~June 3130, 2025, were $~~1,249~~416 and $2,~~498~~914, respectively, compared to $~~-0-~~832 and $23,~~411~~243, respectively, for the three and ~~six~~nine months ended ~~March~~June 3130, 2024, and were from deferred revenue on subscription agreements being recognized.

Revenues consist of our proprietary software, integration consulting services, tech support and product maintenance billed to the customer.

~~Operating~~Cost ~~expenses~~of ~~were~~sales ~~$562,035 and $1,204,241~~ for the three and ~~six~~nine months ended ~~March~~June 3130, 2025, ~~compared~~were to $~~905~~13,~~710~~195 and $150,~~896~~285,~~162~~ ~~for~~respectively, ~~the three~~ and ~~six~~consisted ~~months~~of ~~ended~~hosting ~~March 31, 2024~~fees. ~~The~~There ~~decreases~~was ofno ~~$343,675~~hosting ~~and~~fees ~~$691,921~~ for ~~the~~cost ~~three~~of ~~and~~sales ~~six~~for ~~months ended March 31, 2025, compared to~~ the three and ~~six~~ nine months ended ~~March~~June 3130, 2024~~, are as shown in the table below:~~.

	Three months ended March 31,						Six months ended March 31,
Description	2025			2024			2025			2024
Related party expenses (excluding stock-based compensation)	$	97,955		$	90,000		$	195,910		$	180,000
Stock based compensation		93,628			265,692			228,856			742,000
Stock based compensation, officers		123,383			126,834			247,167			250,042
Professional fees		70,700			61,500			121,349			106,501
Consulting expenses (excluding stock-based compensation)		-			55,000			-			222,000
Depreciation expense		9,161			10,508			19,455			21,084
Software and demo expenses		7,046			187,174			17,694			187,460
General and Administrative, officers		3,146			3,187			1,219			5,805
Auto, travel and entertainment		8,996			14,643			31,157			21,889
Rent expense		13,528			6,372			22,623			13,182
Transfer agent and filing fees		7,277			7,926			14,493			16,610
Investor relations		103,400			57,560			248,667			89,481
Gain on debt extinguishment		(864	)		(8,789	)		(864	)		(4,834	)
Other operating expenses		24,678			28,103			56,514			44,942
Total	$	562,034		$	905,710		$	1,204,241		$	1,896,162

Table of Contents

~~Related~~Operating ~~party~~ expenses ~~(excluding~~were ~~stock~~$360,190 ~~expenses)~~and ~~increased~~$1,564,431 for the three and ~~six~~nine months ended ~~March~~June 3130, 2025, compared to $1,295,747 and $3,191,909 for the three and ~~six~~nine months ended ~~March~~June 3130, 2024. The decreases of $935,557 and $1,627,478 for the three and nine months ended June 30, 2025, compared to the three and nine months ended June 30, 2024, are as ~~follows~~shown in the table below:

	Three months ended March 31,					Six months ended March 31,
	Three months ended June 30,					Nine months ended June 30,
Description	2025		2024			2025			2024
Management fees, Chief Executive Officer (CEO)	$	45,000	$	45,000		$	90,000		$	90,000
Related party expenses (excluding stock-based compensation)	$	98,703	$	97,725		$	294,613		$	277,725
Management fees, Chief Operation Officer (COO)		45,000		45,000			90,000			90,000
Stock based compensation		4,750		575,127			233,606			1,317,127
Office rent and expenses		7,955		-			15,910			-
Stock based compensation, officers		118,158		124,708			365,325			374,750
Total	$	97,955	$	90,000		$	195,910		$	180,000
Professional fees		46,000		51,460			167,349			157,961
Consulting expenses (excluding stock-based compensation)		9,575		237,375			9,575			459,375
Depreciation expense		9,907		10,019			29,362			31,103
Software and demo expenses		835		743			18,529			188,203
General and Administrative, officers		10,525		3,798			18,215			9,603
Auto, travel and entertainment		9,987		13,855			28,747			35,744
Rent expense		11,250		6,748			33,873			19,930
Transfer agent and filing fees		7,909		11,255			22,369			27,865
Investor relations		2,247		147,520			250,914			237,001
Gain on debt extinguishment		-		(9,457	)		(864	)		(14,291	)
Other operating expenses		30,343		24,871			92,818			69,813
Total	$	360,190	$	1,295,747		$	1,564,431		$	3,191,909

~~Effective~~Related ~~January~~party 1,expenses ~~2023,~~(excluding ~~the~~stock ~~monthly~~expenses) ~~fee~~increased for the ~~CEO~~three ~~was $15,000~~ and ~~effective~~nine ~~September~~months 1,ended ~~2023,~~June ~~the monthly fee for the President and COO was $15~~30,~~000.~~ ~~Beginning in April 2024~~2025, ~~the~~compared ~~Company agreed~~ to ~~rent office space for~~ the ~~COO at $2,575 per month plus incidental expenses, on a month to month basis, accordingly, $7,955 and $15,910 is included in related party expenses for the~~ three and ~~six~~nine months ended ~~March~~June 3130, ~~2025~~2024, ~~respectively.~~as follows:

Stock-based compensation expenses decreased in the current periods compared to the prior periods. For the three and six months ended March 31, 2025, stock-based expenses include the compensation of $93,628 and $228,856 related to common stock all previously issued (amortization of prepaids) or to be issued (accrued), pursuant to the terms of each consultant’s contracts. For the three and six months ended March 31, 2024, stock-based expenses , were related to shares issued to consultants of $-0- and $169,200, respectively and the amortization of common stock (pursuant to the terms of each consultant’s contracts), options and warrants of $265,692 and $572,800, respectively.

	Three months ended June 30,				Nine months ended June 30,
Description	2025		2024		2025		2024
Management fees, Chief Executive Officer (CEO)	$	45,000	$	45,000	$	135,000	$	135,000
Management fees, Chief Operation Officer (COO)		45,000		45,000		135,000		135,000
Office rent and expenses		8,703		7,725		24,613		7,725
Total	$	98,703	$	97,725	$	294,613	$	277,725

~~Stock~~Effective ~~based~~January ~~compensation~~1, -2023, ~~officers~~the ~~was~~monthly ~~comprised~~fee ~~pursuant~~for to the ~~agreement~~CEO ~~with~~was ~~the COO (SGG) to issue 250~~$15,000 ~~common shares per month. For the three~~ and ~~six~~effective ~~months~~September ~~ended March 31~~1, ~~2025~~2023, the ~~Company~~monthly ~~recorded~~fee ~~expenses~~for ~~of $18,050 and $36,500, respectively. For~~ the ~~three~~President and ~~six~~COO ~~months~~was ~~ended March 31, 2024, the Company recorded an expense of~~ $2115,~~500 and $39,375 related to the 250,~~000. ~~shares~~Beginning ~~per~~in ~~month.~~April ~~Additionally~~2024, the Company ~~granted~~agreed ~~an option~~ to ~~SGG~~rent (aoffice ~~related~~space ~~party)~~for ~~to purchase 10,000,000 shares of~~ the ~~Company’s~~COO ~~common stock~~ at $~~0.02~~2,575 per ~~share~~month ~~with~~plus anincidental ~~expiry date of July 1~~expenses, ~~2025 (the “CYCA Option”). The CYCA option vests at the rate of 25% beginning~~ on ~~the~~a ~~first six-~~month ~~anniversary of the agreement, as well as a warrant~~ to ~~purchase~~month ~~250~~basis,~~000~~ shares of the Reticulate Micro common stock the Company owns (the “RM Warrant”). The RM Warrant has an exercise price of $1.00 per share and an expiry date of July 1, 2025. The Company valued the CYCA Option at $639,543 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $538,~~295~~703 and $~~106~~24,~~590,~~613 is included in ~~stock-based compensation expense-~~related party expenses for the three and ~~six~~nine months ended ~~March~~June 3130, 2025, ~~and 2024,~~ respectively~~. The Company valued the RM Warrant at $624~~,~~458~~ ~~based on the Black-Scholes option pricing method~~ and ~~will be amortized through the term of the agreement, and accordingly,~~ $527,~~038~~725 ~~and $104,076,~~ is included in ~~stock-based compensation expense-~~related party expenses for the three and ~~six~~nine months ended ~~March~~June 3130, ~~2025, and~~ 2024~~, respectively~~.

~~Professional~~Stock-based ~~fees~~compensation ~~remained~~expenses ~~fairly~~decreased ~~constant~~in ~~for~~the current periods compared to the prior periods. For the three and ~~six~~nine months ended ~~March~~June 3130, 2025, ~~compared~~stock-based expenses include the compensation of $4,750 and $233,606 related to common stock all previously issued (amortization of prepaids) or to be issued (accrued), pursuant to the terms of each consultant’s contracts. For the three and ~~six~~nine months ended ~~March~~June 3130, 2024, stock-based expenses , were related to shares issued to consultants of $300,000 and $469,200, respectively and the amortization of common stock (pursuant to the terms of each consultant’s contracts), options and warrants of $275,127 and $847,927 respectively.

Stock based compensation - officers was comprised pursuant to the agreement with the COO (SGG) to issue 250,000 common shares per month. For the three and nine months ended June 30, 2025, the Company recorded expenses of $12,825 and $49,325, respectively. For the three and nine months ended June 30, 2024, the Company recorded an expense of $19,375 and $58,750 related to the 250,000 shares per month. Additionally, the Company granted an option to SGG (a related party) to purchase 10,000,000 shares of the Company’s common stock at $0.02 per share with an expiry date of July 1, 2025 (the “CYCA Option”). The CYCA option vests at the rate of 25% beginning on the first six-month anniversary of the agreement, as well as a warrant to purchase 250,000 shares of the Reticulate Micro common stock the Company owns (the “RM Warrant”). The RM Warrant has an exercise price of $1.00 per share and an expiry date of July 1, 2025. The Company valued the CYCA Option at $639,543 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $53,295 and $159,885, is included in stock-based compensation expense-related party for the three and nine months ended June 30, 2025, and 2024, respectively. The Company valued the RM Warrant at $624,458 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $52,038 and $156,114 is included in stock-based compensation expense-related party for the three and nine months ended June 30, 2025, and 2024, respectively.

Table of Contents

~~Consulting~~Professional ~~expenses~~fees ~~(excluding~~remained ~~stock~~fairly ~~expenses)~~constant ~~decreased~~for ~~during~~ the three and ~~six~~nine months ended ~~March~~June 3130, 2025, compared to the three and ~~six~~nine months ended ~~March~~June 3130, 2024~~, as certain consultants engaged in the prior periods were not engaged in the current periods~~.

~~Investor~~Consulting ~~relations~~expenses ~~fees~~(excluding ~~increased~~stock ~~for~~expenses) decreased during the three and ~~six~~nine months ended ~~March~~June 3130, 2025, compared to the three and ~~six~~nine months ended ~~March~~June 3130, 2024., ~~The~~as ~~increases~~certain ~~were~~consultants ~~primarily~~engaged ain ~~result of~~ the ~~Company~~prior ~~attending~~periods ~~trade~~were ~~shows~~not ~~and~~engaged ~~conferences~~in ~~to expose~~ the ~~Company~~current ~~to potential investors~~periods.

~~Other~~Investor ~~expense,~~relations ~~net,~~fees decreased for the three and ~~six~~increased for the nine months ended ~~March~~June 3130, 2025, ~~was $860,681 and $925,383, respectively,~~ compared to ~~$82,831 and $153,918 for~~ the three and ~~six~~nine months ended ~~March~~June 3130, 2024~~, respectively~~. The ~~increase~~current ~~was~~three amonth ~~result~~decrease ofwas the ~~issuance~~termination ofwith ~~230,095~~cause ~~shares~~ of ~~RM stock in settlement of $330,000, of principal and $54,820 of accrued interest on convertible notes, where~~ the ~~Company~~investor ~~recognized~~relation ~~a loss of $787,637 for the three and six months ended March 31, 2025~~firm.

	Three months ended March 31,						Six months ended March 31,
Description	2025			2024			2025			2024
Interest expense	$	73,044		$	82,954		$	137,746		$	154,241
Loss on RM shares issued for debt conversions		787,637			-			787,637			-
Unrealized gain on fair value change of marketable securities		(7,661,898	)		-			(7,661,898	)		-
Interest income		-			(123	)		-			(323	)
Total Other Expense (Income)	$	(6,801,217	)	$	82,831		$	(6,736,515	)	$	153,918

For the three months ended June 30, 2025, other expenses were $1,756,292, compared to $158,862 for the three months ended June 30, 2024. The increase was a result of the unrealized loss on the change in fair value of the RM common stock (marketable securities). For the nine months ended June 30, 2025, other income was $4,980,223 compared to other expense of $312,780 for the nine months ended June 30, 2024. For the nine months ended June 30, 2025, other income of $4,980,223, was the result of the $5,919,760 unrealized gain on the fair value change of the RM common stock, partially offset by the loss on settlement of debt.

~~The~~Interest ~~following~~expense ~~tables~~decreased ~~set~~for ~~forth~~the ~~key~~three ~~components~~and ofnine ~~our~~months ~~balance~~ended ~~sheet~~June ~~as of March 31~~30, 2025, compared to the three and ~~September~~nine months ended June 30, 2024, due to settlements of notes payable.

	March 31,2025		September 30,2024
	Three months ended June 30,					Nine months ended June 30,
Current Assets	$	7,492,228	$	1,983,881
Description	2025		2024			2025			2024
Long term assets	$	34,412	$	191,310
Interest expense	$	14,154	$	159,041		$	151,900		$	313,282
Total Assets	$	7,526,640	$	2,175,191
Loss on RM shares issued for debt conversions		-		-			787,637			-
Current and Total Liabilities	$	1,352,688	$	2,412,635
Unrealized gain on fair value change of marketable securities		1,742,138		-			(5,919,760	)		-
Stockholders’ Equity (Deficit)	$	6,173,952	$	(237,444	)
Interest income		-		(179	)		-			(502	)
Total Liabilities and Stockholders’ Equity (Deficit)	$	7,526,640	$	2,175,191
Total Other Expense (Income)	$	1,756,292	$	158,862		$	(4,980,223	)	$	312,780

~~Liquidity~~The following tables set forth key components of our balance sheet as of June 30, 2025, and ~~Capital~~September ~~Resources~~30, 2024.

As of March 31, 2025, we had limited operating capital. Our current capital and our other existing resources will not be sufficient to provide the working capital needed for our current business. Additional capital will be required to meet our obligations, and to further expand our business. We may be unable to obtain the additional capital required. Our inability to generate capital or raise additional funds when required will have a negative impact on our business development and financial results. These conditions raise substantial doubt about our ability to continue as a going concern as well as our recurring losses from operations and the need to raise additional capital to fund operations. This “going concern” could impair our ability to finance our operations through the sale of debt or equity securities.

	June 30, 2025		September 30, 2024

Current Assets	$	5,429,073	$	1,983,881

Long term assets	$	24,505	$	191,310

Total Assets	$	5,453,578	$	2,175,191

Current and Total Liabilities	$	1,408,886	$	2,412,635

Stockholders’ Equity (Deficit)	$	4,044,692	$	(237,444	)

Total Liabilities and Stockholders’ Equity (Deficit)	$	5,453,578	$	2,175,191

Table of Contents

~~The~~Liquidity ~~accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets~~ and ~~the~~Capital satisfaction of liabilities in the normal course of business. As of March 31, 2025, the Company had an accumulated deficit of $31,370,211 and limited revenue. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these uncertainties. The Company intends to fund operations through equity and/or debt financing arrangements, which may not be sufficient to fund its capital expenditures, working capital and other cash requirements for the foreseeable future.Resources

As of ~~March~~June 3130, 2025, we had ~~cash~~limited ofoperating ~~$629,061~~capital. ~~compared~~Our tocurrent ~~$1,439,835~~capital atand ~~September~~our ~~30,~~other ~~2024.~~existing Asresources ofwill ~~March~~not ~~31,~~be ~~2025,~~sufficient weto ~~had~~provide the working capital needed for our current ~~assets~~business. Additional ofcapital $7will be required to meet our obligations,~~492,228~~ and ~~current~~to ~~liabilities~~further ofexpand ~~$1,352,687,~~our ~~which~~business. ~~resulted~~We inmay ~~working~~be ~~capital~~unable ofto ~~$6,139,540~~obtain the additional capital required. ~~The~~Our ~~current~~inability ~~liabilities~~to ~~are~~generate ~~comprised~~capital ofor ~~accounts~~raise ~~payable~~additional funds when required will have a negative impact on our business development and ~~accrued~~financial ~~expenses,~~results. ~~related~~These ~~party~~conditions ~~liabilities,~~raise ~~convertible~~substantial ~~notes~~doubt ~~payable,~~about our ability to continue as a going concern as well as our recurring losses from operations and ~~deferred~~the ~~revenue~~need to raise additional capital to fund operations. This “going concern” could impair our ability to finance our operations through the sale of debt or equity securities.

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of June 30, 2025, the Company had an accumulated deficit of $33,499,472 and limited revenue. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern. The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of these uncertainties. The Company intends to fund operations through equity and/or debt financing arrangements, which may not be sufficient to fund its capital expenditures, working capital and other cash requirements for the foreseeable future.

As of June 30, 2025, we had cash of $416,892 compared to $1,439,835 at September 30, 2024. As of June 30, 2025, we had current assets of $5,429,073 and current liabilities of $1,408,886, which resulted in working capital of $4,020,187. The current liabilities are comprised of accounts payable and accrued expenses, related party liabilities, dividend payable and convertible notes payable.

Operating Activities

For the ~~six~~nine months ended ~~March~~June 3130, 2025, net cash used in operating activities was $~~807~~1,~~774~~019,943 compared to $~~790~~1,~~660~~411,364 for the ~~six~~nine months ended ~~March~~June 3130, 2024. For the ~~six~~nine months ended ~~March~~June 3130, 2025, our net cash used in operating activities was primarily attributable to net income of $53,~~497~~368,~~681~~421, adjusted by the unrealized gain on the fair value change of marketable securities of $75,~~661~~919,~~898~~760, the loss on issuance of RM stock in settlement of debt conversions of $787,637, stock-based compensation of $~~476~~608,~~203~~931, and depreciation of $1929,~~455~~362. Net changes of $74106,~~191~~330 in operating assets and liabilities ~~increased~~decreased the cash used in operating activities.

For the ~~six~~nine months ended ~~March~~June 3130, 2024, our net cash used in operating activities was primarily attributable to the net loss of $23,~~047~~501,~~669~~446 ~~and gain on debt extinguishment of $4,834,~~ adjusted by stock-based compensation of $~~992~~1,~~042~~691,877, amortization of note discounts of $3046,~~706~~060, gain on debt extinguishment of $14,291 and amortization and depreciation of $2131,~~084~~103. Net changes of $~~218~~335,~~011~~333 in operating assets and liabilities decreased the cash used in operating activities.

Investing Activities

For the ~~six~~nine months ended ~~March~~June 3130, 2025, the Company purchased $3,000 of property and equipment. For the ~~six~~nine months ended ~~March~~June 3130, 2024, ~~there~~the ~~was~~Company nospent ~~cash~~$14,707 ~~provided~~for bythe orpurchase ~~used~~of inproperty ~~investing~~and ~~activities~~equipment.

Financing Activities

For the ~~six~~nine months ended ~~March~~June 3130, 2025, there were no financing activities.

For the ~~six~~nine months ended ~~March~~June 3130, 2024, the Company received $~~557~~2,~~500~~468,450 in exchange for the issuance of various convertible promissory notes.

Critical Accounting Policies

Our significant accounting policies are summarized in Note 3 of our financial statements. While all these significant accounting policies impact our financial condition and results of operations, we view certain of these policies as critical. The SEC requested that all registrants list their most “critical accounting polices” in the Management Discussion and Analysis. The SEC indicated that a “critical accounting policy” is one which is both important to the portrayal of a company’s financial condition and results, and requires management’s most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Our management believes that given current facts and circumstances, there are no material estimates or assumptions with levels of subjectivity and judgement necessary to be considered critical accounting policies.

Table of Contents

Off Balance Sheet Arrangements

We have no off-balance sheet arrangements, including arrangements that would affect our liquidity, capital resources, market risk support and credit risk support or other benefits.

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

Not Applicable.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

28We ~~Table~~carried out an evaluation, under the supervision and with the participation of ~~Contents~~our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures as of June 30, 2025. Based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses found in our internal controls over financial reporting, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective for the reasons discussed below.

WeA ~~carried~~material ~~out~~weakness anis ~~evaluation~~a deficiency, ~~under~~or ~~the~~combination ~~supervision~~of ~~and~~deficiencies, ~~with~~in ~~the~~internal ~~participation~~control ofover ~~our~~financial ~~management~~reporting, ~~including~~such ~~our~~that ~~Chief~~there ~~Executive~~is ~~Officer~~a ~~and~~reasonable ~~Chief~~possibility ~~Financial~~that ~~Officer,~~a material misstatement of the ~~effectiveness~~Company’s ofannual ~~our~~or ~~disclosure~~interim ~~controls~~financial ~~and~~statements ~~procedures~~will asnot ofbe ~~March~~prevented ~~31,~~or ~~2025.~~detected ~~Based~~ on ~~the~~a ~~evaluation~~timely ofbasis. ~~these~~In ~~disclosure~~its ~~controls~~assessment ~~and procedures, and in light~~ of the ~~material~~effectiveness ~~weaknesses~~of ~~found in our~~ internal ~~controls~~control over financial reporting, ~~our~~as ~~Chief~~of ~~Executive~~June ~~Officer~~30, ~~and~~2025, ~~Chief~~the ~~Financial~~Company ~~Officer~~determined ~~concluded~~ that ~~our~~there ~~disclosure~~were ~~controls~~control ~~and~~deficiencies ~~procedures~~that ~~were~~constituted ~~not~~material ~~effective~~weaknesses, ~~for~~as ~~the~~described ~~reasons discussed~~ below.

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of March 31, 2025, the Company determined that there were control deficiencies that constituted material weaknesses, as described below.

	1.	We do not have an Audit Committee – While not being legally obligated to have an audit committee, it is the management’s view that such a committee, including a financial expert member, is an utmost important entity level control over the Company’s financial statement. Currently the Board of Directors acts in the capacity of the Audit Committee, and does not include a member that is considered to be independent of management to provide the necessary oversight over management’s activities.

	2.	We did not maintain appropriate cash controls – As of June 30, 2025, the Company has not maintained sufficient internal controls over financial reporting for cash, including failure to segregate cash handling and accounting functions, and did not require dual signatures on the Company’s bank accounts.

	1.	We do not have an Audit Committee – While not being legally obligated to have an audit committee, it is the management’s view that such a committee, including a financial expert member, is an utmost important entity level control over the Company’s financial statement. Currently the Board of Directors acts in the capacity of the Audit Committee, and does not include a member that is considered to be independent of management to provide the necessary oversight over management’s activities.
	2.	We did not maintain appropriate cash controls – As of March 31, 2025, the Company has not maintained sufficient internal controls over financial reporting for cash, including failure to segregate cash handling and accounting functions, and did not require dual signatures on the Company’s bank accounts.

Accordingly, the Company concluded that these control deficiencies resulted in a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis by the company’s internal controls.

Our management, including our Chief Executive Officer and our Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

Changes in Internal Controls over Financial Reporting

There has been no change in our internal control over financial reporting occurred during the six months ended ~~March~~June 3130, 2025, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II. OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS

None.

Item 1A. RISK FACTORS

Not applicable for smaller reporting companies.

Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On January 23, 2025, the Company issued 180,000 shares of restricted common stock in settlement of $4,500 of accrued interest.

On January 27, 2025, the Company issued 180,000 shares of restricted common stock in settlement of $4,500 of accrued interest.

Item 3. DEFAULTS UPON SENIOR SECURITIES

None.

Item 4. MINE SAFETY DISCLOSURE

Not applicable.

Item 5. OTHER INFORMATION

	(a)	None.
	(b)	During the quarter ending ~~March~~June 3130, 2025, there have not been any material changes to the procedures by which security holders may recommend nominees to the Board of Directors.

Table of Contents

Item 6. EXHIBITS

The following documents are filed as part of this report:

Exhibit No.		Description
3.1		Articles of Incorporation of Cytta Corp.*
3.2		Bylaws of the Company *
3.3		Amendment to Articles of Incorporation Amending Authorized Common and Preferred Stock *
3.4		Amended and Restated Certificate of Designation of Series D Preferred Stock *
3.5		Amended and Restated Certificate of Designation of Series E Preferred Stock *
3.6		Certificate of Designation of Series F Preferred Stock**
10.1		Agreement by and between Cytta Corp and Makena Investment Advisors, LLC dated April 1, 2020 *
10.2		Sublease Agreement by and between Cytta Corp and Michael Collins dated October 25, 2020 *
10.3		Agreement by and between Cytta Corp and Peter Rettman dated August 27, 2020 *
10.4		Share Issuance agreement by and between Cytta Corp and United Financial Inc., dated September 30, 2020 *
10.5		Technology Access Agreement by and between Cytta Corp and Michael Collins dated July 19, 2018 *
14.1		Code of Ethics *
31.1		Certification of Chief Executive Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002***
31.2		Certification of Chief Financial Officer required by Rule 13a-14(1) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002***
32.1		Certification of Chief Executive Officer and the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and Section 1350 of 18 U.S.C. 63***
101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).***
101.SCH		Inline XBRL Taxonomy Extension Schema Document.***
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.***
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.***
101.LAB		Inline XBRL Taxonomy Extension Labels Linkbase Document.***
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.***
104		Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).

* Incorporated by reference to the same exhibit to the registration statement filed by the Company on June 28, 2021.

** Incorporated by reference to exhibit 4.1 to the Current Report on Form 8-K filed by the Company on November 26, 2021.

*** Filed herewith

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: ~~September~~October 30, 2025

/s/ Gary Campbell
Gary Campbell
Chief Executive Officer
(principal executive officer)
(principal financial and accounting officer)

Filing Compare · CYTTA CORP.